PGI29 Predictors of Nonpersistence and Nonadherence with Oral 5-Aminosalicylic Acid Therapy in Patients with Ulcerative Colitis (Englisch)
- Neue Suche nach: Yen, L.
- Neue Suche nach: Wu, J.
- Neue Suche nach: Hodgkins, P.
- Neue Suche nach: Nichol, M. B.
- Neue Suche nach: Yen, L.
- Neue Suche nach: Wu, J.
- Neue Suche nach: Hodgkins, P.
- Neue Suche nach: Nichol, M. B.
In:
VALUE IN HEALTH
;
15
, 4
;
A140
;
2012
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:PGI29 Predictors of Nonpersistence and Nonadherence with Oral 5-Aminosalicylic Acid Therapy in Patients with Ulcerative Colitis
-
Beteiligte:
-
Erschienen in:VALUE IN HEALTH ; 15, 4 ; A140
-
Verlag:
- Neue Suche nach: Blackwell Publishing Ltd
-
Erscheinungsdatum:01.01.2012
-
Format / Umfang:A140
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 610
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 610 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 15, Ausgabe 4
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- A2
-
ME2 Effect of Medicare Prescription Drug Program (Part D) on Medication Adherence for Dual Eligibles: Case of ACEIs and ARBsKim, J. A. / Park, T. et al. | 2012
- A3
-
RM3 Antipsychotic Use and Risk of All-Cause Mortality in Elderly Dual Eligible BeneficiariesAparasu, R. R. / Chatterjee, S. / Mehta, S. / Chen, H. et al. | 2012
- A4
-
SB4 Propensity-Score Matching (PSM) to Control for Selection Bias in “Real-World” Treatment Comparisons: A Cautionary Tale Concerning Antibiotic Therapy for Infectious DiseaseBerger, A. / Mckinnon, P. S. / Larson, K. / Crompton, M. / Hennegan, K. / Weber, D. J. / Boening, A. J. / Oster, G. et al. | 2012
- A5
-
CV1 Differences in Processes and Outcomes of Care in Elderly Hypertensive Diabetic Patients With and Without DementiaChitnis, A. S. / Johnson, M. L. et al. | 2012
- A6
-
DR2 The Relationship Between Pseudoephedrine Sales and Clandestine Methamphetamine LabsTalbert, J. / Blumenschein, K. / Freeman, P. R. et al. | 2012
- A10
-
PR1 FDA Actions Against Health Economic Promotions, 2002-2011Neumann, P. J. / Bliss, S. et al. | 2012
- A11
-
QU2 Cross-Cultural Psychometric Evaluation of the Ensemble MDSBushnell, D. M. / Mccarrier, K. P. / Martin, M. L. / Paczkowski, R. / Shen, W. / Buesching, D. et al. | 2012
- A14
-
PHP10 Australia's Rule of Rescue and the Life Saving Drugs Programme: Same-Same But Different?Priest, V. L. / Dummett, H. et al. | 2012
- A15
-
PHP15 What Price do we Pay for Repurposing Medicines for Rare Diseases?Simoens, S. / Picavet, E. / Cassiman, D. / Dooms, M. et al. | 2012
- A16
-
PHP21 Complementary and Alternative Medicine Use Among People With Disabilities: NHIS 2007 SurveyVohra, R. / Pan, X. L. / Sambamoorthi, U. et al. | 2012
- A17
-
PHP26 Multimorbidity and PolypharmacyVyas, A. / Pan, X. L. / Sambamoorthi, U. et al. | 2012
- A19
-
PHP38 Out-of-Pocket Drug Expenditure Among Users of the Ambulatory Care Services at the Mexican Institute of Social Security (IMSS)Uc-Coyoc, R. / Pé / rez-Reynaud, A. G. / Coello-Reyes, L. A. / Rodriguez-Dí / az Ponce, M. A. et al. | 2012
- A21
-
PHP50 The Health and Economics Bulletin – an Analysis of Three Years of PublicationLima, S. O. / Calais, G. S. / Caldeira, T. R. / Garcia, G. C. / Gava, C. M. / Pereira, R. F. / Ronchini, M. A. / Troncoso, G. C. et al. | 2012
- A22
-
PHP55 Evidence Based Advertisement: Where is the Pharmacoeconomic and Humanistic Outcomes Research Evidence?Muragundi, P. M. / Chandu Sagar, N. / Aishwarya, K. / Udupa, N. / Naik, A. N. et al. | 2012
- A24
-
PHP66 Assessing Agreement Between Patient Access Schemes: Review of Nice and SMC GuidanceTimm, B. / Leonard, S. A. / Haynes, S. et al. | 2012
- A25
-
PHP71 Pharmacoeconomic Education in Schools and Colleges of Pharmacy in 2011 in the United StatesMakhinova, T. / Rascati, K. L. et al. | 2012
- A26
-
PHP77 Technological Intervention: Nurses' Perception Regarding Performance Obstacles and Ease of WorkHatfield, M. D. / Dwibedi, N. / Frost, C. P. / Sansgiry, S. S. et al. | 2012
- A27
-
PHP83 Community Health Workers: A Literature Review in Some Countries of South AmericaBorda-Olivas, A. / Palma-Ruiz, M. / Drasbek, C. / Sarria-Santamera, A. et al. | 2012
- A28
-
PHP88 National Patterns and Trends of Off-Label Use of Antipsychotic Medications in the Elderly Following FDA Black Box WarningsTeigland, C. / Jones, B. T. / Parente, A. K. / Wang, R. H. / Yin, S. et al. | 2012
- A29
-
PHP93 Impact of Prescription Monitoring Programs on Pharmacists' Controlled Substance Dispensing BehaviorWixson, S. E. / Talbert, J. / Blumenschein, K. / Freeman, P. R. et al. | 2012
- A31
-
PHP104 Potential Implications of National Disease Registries and Centers of Excellence for Orphan Diseases for Pharmaceutical Manufacturers Developing Orphan DrugsDobrovolny, D. / Patel, A. / Dalsania, R. / Paas, M. et al. | 2012
- A33
-
PMS3 Comparative Effectiveness Analysis Using “Real-World” Patient Database to Evaluate the Fractures Rates Comparing Annual Zoledronic Acid Infusion with Oral BisphosphonatesLian, J. / Song, X. / Varker, H. / Cao, Z. / Recknor, C. et al. | 2012
- A35
-
PMS14 Health Care Costs and Opioid Use among Patients with Osteoarthritis Initiating Duloxetine Versus Other TreatmentsHong, J. / Peng, X. / Andrews, J. S. / Novick, D. et al. | 2012
- A36
-
PMS19 Impact of Disease Severity on the Total, Health-Related, Financial Costs of Treatment of People with Rheumatoid Arthritis in the United KingdomPoole, C. D. / Currie, C. J. / Holden, S. / Singh, A. et al. | 2012
- A37
-
PMS24 Cost and Pattern of Motorcycle Accidents at a Tertiary Care Hospital in SindhKhowaja, M. A. et al. | 2012
- A38
-
PMS29 Cost-Effectiveness of Collagenase Clostridium Histolyticum, Limited Fasciectomy, and Percutaneous Needle Fasciotomy in the Treatment of Dupuytren's ContractureMalone, D. C. / Armstrong, E. P. et al. | 2012
- A39
-
PMS35 The Cost-Effectiveness of Pegloticase in the Treatment of Refractory Chronic GoutWang, B. C. / Garrison, L. et al. | 2012
- A42
-
PMS50 Benefits in Patient Reported Outcomes Supporting a “Treat to Target” Paradigm for Infliximab -Treated RA Patients Previously Inadequately Responsive to Prior Anti-TNF TreatmentIngham, M. / Tang, L. / Decktor, D. / Bolce, R. / Wang, J. et al. | 2012
- A43
-
PMS55 Quality of Life among Patients with Self-Reported Rheumatoid Arthritis: A Nationally Representative SampleRappaport, H. et al. | 2012
- A44
-
PMS60 Infliximab Therapy Improves the Quality of Life of Ankylosing Sporidylitis Patients in ChinaWang, N. S. / Bi, L. Q. / Chen, J. W. / He, D. Y. / Wu, L. J. / Lin, J. / Chang, J. H. / Li, J. G. / Feng, W. et al. | 2012
- A45
-
PMS66 Satisfaction with and Preference for Golimumab and its Auto-Injector among Rheumatoid Arthritis Patients Switched from Adalimumab or EtanerceptTandon, N. / Bolce, R. / Naim, A. / Bolge, S. / Ellis, L. / Piech, C. T. / Decktor, D. et al. | 2012
- A46
-
PMS71 Cost-Effectiveness of Alendronate Therapy for Osteopenic Postmenopausal Women in JapanMoriwaki, K. / Komaba, H. / Noto, S. / Yanagisawa, S. / Inoue, H. / Takeshi, T. / Fukagawa, M. / Takahashi, H. E. et al. | 2012
- A49
-
PMS87 Osteoarthritis in France the Cost of Ambulatory Care in 2010Taieb, C. et al. | 2012
- A50
-
PMS92 Adaptation and Validation of an Indian Version of the Health Related Quality of Life Scale (IND-HAQ) in Indian Patients with Rheumatoid ArthritisKhera, K. / Nagappa, A. N. / Balakrishnan, R. / Sharma, S. et al. | 2012
- A51
-
PRS3 Inhaled Anticholinergics and Risk of All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease: a Systematic Review and Meta Analysis of Randomized Controlled TrialsAjmera, M. R. / Rane, P. B. / Kelley, G. / Sambamoorthi, U. et al. | 2012
- A52
-
PRS8 Evaluation of the Association Between Statin Use and Risk of Chronic Obstructive Pulmonary Disease ExacerbationWang, M. T. / Lo, Y. W. et al. | 2012
- A53
-
PRS14 Cost-Effectiveness of Azithromycin and Clarithromycin Treatments for Community Acquired Pneumonia Requiring Hospitalization for Immunocompetent Individuals of Age 65 and Older, from Private Perspective in BrazilFujii, R. K. / Mould, J. F. / Lanzara, G. D. / Manfrin, D. F. et al. | 2012
- A54
-
PRS19 Exacerbations and Costs in Chronic Bronchitis Patients Treated with Copd Medications from a Managed Care Population in the United StatesAbudagga, A. / Sun, S. X. / Tan, H. / Kavati, A. / Solem, C. T. / Botteman, M. F. et al. | 2012
- A55
-
PRS24 Cost-Effectiveness Analysis of Voriconazole, Amphotericin B and Caspofungin for Invasive Aspergilosis Patients in Public Hospitals in Dominican RepublicLutz, M. A. / Blanco, C. / Baudrit, M. / Cuesta, G. et al. | 2012
- A56
-
PRS29 Health Care Resource Utilization and Costs in Chronic Bronchitis Patients Treated with Copd Medications from a Managed Care Population in the United StatesAbudagga, A. / Sun, S. X. / Tan, H. / Kavati, A. / Solem, C. T. / Botteman, M. F. et al. | 2012
- A57
-
PRS34 The Burden of Asthma in Brazil from the Patient'S PerspectiveVietri, J. / Pomerantz, D. et al. | 2012
- A58
-
PRS39 Palavizumab (Synagis) Use and Outcomes Among Medicaid BeneficiariesDatar, M. / Banahan, B. F. / Null, K. D. / Hardwick, S. P. / Clark, J. P. et al. | 2012
- A59
-
PRS44 Education Plays a Vital Role in the Attitude Toward the Usage of Protective Methods and Resulting Lesser Morbidities among Agate WorkersAggarwal, B. D. et al. | 2012
- A60
-
PRS49 All-Cause 30-Day Readmissions for Matched Inpatients with Copd Receiving Nebulized Short-Acting or Long-Acting Beta AgonistsBollu, V. / Robinson, S. B. / Karafilidis, J. / Rajagopalan, K. / Johnson, B. H. / Walsh, J. S. / Ernst, F. R. / Braman, S. et al. | 2012
- A61
-
PRS55 A New Concept of Patient Reported Outcome on Quality Indicators for Pharmaceutical CareHuttin, C. et al. | 2012
- A62
-
PMD5 Use and Findings of K-Ras in Colorectal Cancer (CRC) Testing in Administrative and Electronic Medical Records (EMR) Data from 2005 Through 2010Seal, B. / Sullivan, S. D. / Ramsey, S. / Kreilick, C. / Foltz-boklage, S. / Haslip, S. / Gilmore, J. / Sarma, S. / Asche, C. / Valluri, S. et al. | 2012
- A63
-
PMD11 Budget Impact of Converting Standard Treatment of Menorrhagia from Rollerball to Thermal Balloon Ablation in Canadian HospitalsGoldstein, L. J. et al. | 2012
- A64
-
PMD16 Forecasting the Prevalence and Economic Burden of Atrial Fibrillation in Selected Countries, 2010 - 2025Rizzo, J. A. / Mallow, P. / Waters, H. / Cirrincione, A. et al. | 2012
- A65
-
PMD22 Comparative Cost Between Vertebroplasty and Kyphoplasty for the Treatment of Vertebral Compression FracturesOng, K. L. / Lau, E. / Kemner, J. E. / Kurtz, S. M. et al. | 2012
- A66
-
PMD27 Cost-Effectiveness of Sacral Nerve Stimulation in Refractory Overactive Bladder: A Canadian PerspectiveSadri, H. / Corcos, J. / Dwyer, N. / Gajewski, J. / Gray, G. / Hassouna, M. / Robert, M. / Tu, L. et al. | 2012
- A67
-
PMD32 Cost-Effectiveness of Drug-Eluting Stents Versus Bare-Metal Stents for Single- and Multi-Vessel Percutaneous Coronary InterventionYan, B. / Lee, V. / Liu, M. / Reid, C. / Yu, C. M. et al. | 2012
- A68
-
PMD38 Cost Minimization Analysis of a Multi-Site Randomized Clinical Trial of Home-Based Versus Laboratory-Based Testing for the Diagnosis and Treatment of Obstructive Sleep Apnea (HomePAP Study)Kim, R. D. / Kapur, V. K. / Redline bruch, J. / Rueschman, M. / Rosen, C. L. / Redline, S. / Ramsey, S. et al. | 2012
- A69
-
PMD43 Preferences of Multiple Sclerosis Patients for Attributes of Self-Injection DevicesSwinburn, P. / Shingler, S. L. / Ali, S. / Perard, R. / Lloyd, A. J. et al. | 2012
- A70
-
PMD49 Do HTA Requirements and Procurement Incentives in Medical Devices Need Re-Aligning?Griffin, A. D. / Chambers, G. / Wilsdon, T. et al. | 2012
- A71
-
PMD54 Urine Drug Monitoring in the Clinic – Who are We Testing, What are We Testing for, and How Often are We Testing?Clancy, Z. A. / Couto, J. / O' / Connell, K. / Moore, N. / Romney, M. et al. | 2012
- A72
-
PMD60 Design of a Bayesian Network As a Decision Model for the Diagnosis of AppendicitisCastillo, M. / Bernal, A. J. / Fajardo, R. et al. | 2012
- A73
-
PSU3 Analysis of Bariatric Outcomes Longitudinal Database (BOLD) to Predict Percent BMI Loss After Bariatric SurgeryBenoit, S. C. / Francis, D. M. / Hunter, T. D. et al. | 2012
- A74
-
PSU8 Disease Burden and Medical Needs in Older Patients with Total Knee Arthroplasties and Muscle Atrophy or WeaknessGreen, J. / Hallett, L. / Zhao, Y. / Birt, J. / Foster, T. et al. | 2012
- A75
-
PSU13 Cost Analysis of Cell Salvage in Pediatric SurgerySamnaliev, M. / Tran, C. / Gasior, I. / Sloan, S. R. / Lightdale, J. / Brustowicz, R. et al. | 2012
- A76
-
PSU19 Comparison of Cost and Operating Room Time of Low Anterior Resection (LAR) Versus Abdominoperineal Resection (APR) Procedures in the United StatesHashemi, L. / Geraci, D. et al. | 2012
- A77
-
PSU24 Cost-Effectiveness of Bariatric Surgery: Laparoscopic Gastric Bypass and BandingMatsuda, T. / Hay, J. et al. | 2012
- A78
-
PSU29 The Importance of Medical Appointments After Roux-en-Y Gastric Bypass in Morbid Obese Patients: Association Between Adherence to Medical Follow-Up Visits and the Bariatric Analysis and Reporting Outcome System (BAROS) Score Based on an Administrative Database (DATASUS) in BrazilAsano, E. / Rasera, I. / Shiraga, E. C. / Cunha, P. G. et al. | 2012
- A79
-
PSU34 Rates and Costs of Hospitalization in Obese Patients with Bariatric SurgeryLao, W. L. / Chia, J. / Globe, D. et al. | 2012
- A81
-
PMH4 Comparison of Risk Adjustment Methods in Predicting Health Care Expenditure among Children with Attention Deficit/Hyperactivity DisorderBali, V. / Johnson, M. L. / Aparasu, R. R. et al. | 2012
- A82
-
PMH9 Description of the Burden Associated with Cognition Deficits in SchizophreniaMillier, A. / Aballea, S. / Toumi, M. / Azorin, J. M. et al. | 2012
- A83
-
PMH14 Predictors of Ambulatory Visit Utilization among Patients with Attention Deficit/Hyperactivity Disorder in the United StatesBali, V. / Franzini, L. et al. | 2012
- A84
-
PMH19 Combination Utilization Patterns and Treatment Predictors in ADHD in a Commercially Insured PopulationBernauer, M. / Farr, A. / Haynes, V. / Montejano, L. B. / Lenhart, G. / Pohl, G. / Kelsey, D. et al. | 2012
- A85
-
PMH24 Differences in Health Care Utilization and Associated Costs Between Patients Prescribed Versus not Prescribed Opioids During an Inpatient or Emergency Department VisitXie, L. / Joshi, A. V. / Harnett, J. / Mardekian, J. / Schaaf, D. / Shah, N. / Baser, O. et al. | 2012
- A86
-
PMH29 Estimates of Schizophrenia-Related Direct Medical Costs Using Attributable and Incremental Cost ApproachesDesai, P. / Lawson, K. et al. | 2012
- A88
-
PMH40 National Estimates and Potential Predictors of Emergency Department (ED) and Inpatient Care Costs for Events Related to Abuse or Misuse of Opioid AnalgesicsChandwani, H. / Strassels, S. / Rascati, K. L. / Lawson, K. / Wilson, J. P. et al. | 2012
- A89
-
PMH45 Utility Scores Associated with the World Health Organisation Drinking Risk-Level Classification in Alcohol DependenceSanglier, T. / Laramé / e, P. / Millier, A. / Guennec, M. / Marteau, F. / Daeppen, J. B. et al. | 2012
- A90
-
PMH50 Psychiatrists' Preferences for Attributes of Antipsychotic Medications to Treat Schizophrenia: A Conjoint AnalysisGelhorn, H. / Gries, K. S. / Cho, C. / Thompson, C. / Fastenau, J. et al. | 2012
- A91
-
PMH55 Racial and Ethnic Differences in ADHD in Young and Adolescent Children: Parental Reports in the Medical Expenditure Panel Survey 2008Yeola, D. C. / Franzini, L. et al. | 2012
- A92
-
PMH60 Health-Related Quality of Life (HRQOL) among Survivors 8 Months and 3 Years After Sichuan 2008 Earthquake in ChinaKe, X. / Chen, Y. / Mock, N. / Shi, L. et al. | 2012
- A93
-
PMH66 Growth in Antidepressant Use in 10 Countries in the Last DecadeMilea, D. / Bent-ennakhil, N. / Jaroslawski, S. / Zard, J. / Toumi, M. et al. | 2012
- A94
-
PMH71 Treatment Utilization Patterns and Expenditures in Depressed Older Adults in the United States: Results from Medical Expenditure Panel SurveyMehta, S. / Aparasu, R. R. et al. | 2012
- A95
-
PMH77 Atypical Antipsychotic Black Box Warning and its Effect on Non-Antipsychotic Psychotropic Drugs in Non-Institutionalized Dementia PatientsSingh, R. R. / Nayak, R. et al. | 2012
- A96
-
PMH82 Do Sales of Pseudoephedrine Predict Methamphetamine-Related Hospitalizations?Freeman, P. R. / Blumenschein, K. / Talbert, J. et al. | 2012
- A97
-
PMH87 Cross-Cultural Adaptation of a Research Version of the Rey Auditory Verbal Learning Test (RAVLT) into (US) SpanishRendu, E. / Caveney, A. / Miner, A. / Nomikos, A. / Acquadro, C. et al. | 2012
- A98
-
PSY4 Prevalence of Autoimmune Diseases and Other Comorbidities in Patients With Psoriasis in the United StatesZhang, F. / Guerin, A. / Gauthier, G. / Day, R. / Khan, Z. et al. | 2012
- A99
-
PSY9 Prevalence of Opioid Abuse and Associated Health Care Resource Utilization and Costs in a Managed Care PopulationRoland, C. L. / Joshi, A. V. / Mardekian, J. / Walden, S. C. / Harnett, J. et al. | 2012
- A100
-
PSY14 Health Care Costs and Opioid Use among Patients With Chronic Low Back Pain Initiating Duloxetine Versus Other TreatmentsHong, J. / Peng, X. / Andrews, J. S. / Novick, D. et al. | 2012
- A101
-
PSY19 Burden of Illness (BOI) of FLT3-Mutated Acute Myeloid Leukemia (AML)Sotak, M. L. / Marin, M. / Coombs, J. / Schiller, G. J. / Teitelbaum, A. et al. | 2012
- A102
-
PSY24 Association of Patient Cost or Reimbursement Challenges With Health Care Resource Utilization, Quality of Life, and Work Productivity Among Patients With Inflammatory Bowel DiseaseVanderpoel, J. / Lofland, J. / Schenkel, B. / Dibonaventura, M. D. / Gross, H. et al. | 2012
- A103
-
PSY30 Cost Utility Analysis of the Profilaxis Versus On-Demand Treatment With Recombinant Factor IX for the Treatment of Hemophilia B in MexicoMuciñ / o-Ortega, E. / Leyva-Bravo, V. / Gutié / rrez, C. / Galindo-Suá / rez, R. M. et al. | 2012
- A104
-
PSY35 Economic Evaluation of Lenalidomide in the Management of Previously Treated Multiple Myeloma (PTMM) Patients in GreeceFragoulakis, V. / Kourlaba, G. / Maniadakis, N. et al. | 2012
- A105
-
PSY40 Are Neuropathic Pain (NP) Treatment Benefits Reflected in the Self Assessment of Treatment (SAT) Questionnaire?Wiklund, I. / Holmstrom, S. / Wyrwich, K. / Devine, M. / Stoker, M. et al. | 2012
- A106
-
PSY45 Examining Psoriasis Patient Perspectives of Disease and Treatment: A Novel Multi Discriminate ApproachNaim, A. / Gollins, J. R. / Chen, W. / Walls, D. et al. | 2012
- A107
-
PSY50 Smoking Cessation Medication Utilization Pattern Among Adult Smokers With Different Body Weight Levels – a NAMCS StudyYang, M. / Yu, Y. / Rajan, S. S. / Essien, E. J. / Abughosh, S. et al. | 2012
- A109
-
PSY61 Baseline Characteristics of Over 5,000 Patients Using Nplate® (Romiplostim) in the Nplate® NEXUS (Network of Experts Understanding and Supporting Nplate®) Program, the Nplate® REMS (Risk Evaluation and Mitigation Strategy) Patient RegistrySmith, S. / Batra, M. / Cha, S. / Aycock, J. / Gardner, S. / Eisen, M. et al. | 2012
- A110
-
PSY66 Use of Medicaid Analytic Extract for Evaluation of Drug Use and Health Services Utilization in Patients With HemophiliaBykov, K. / Bohn, R. L. / Ewenstein, B. M. / Avorn, J. L. / Seeger, J. D. et al. | 2012
- A111
-
PCV3 Evaluation of VTE Prophylaxis, Surgical Site Bleeding, and Surgical-Site Infections Following Orthopaedic Arthroplasty: A Nested Case–Control Medical Chart Review StudyFisher, M. / Klaskala, W. / Fields, L. E. / Mills, R. M. / Stephenson, J. J. / Fu, A. C. / Huo, M. et al. | 2012
- A112
-
PCV8 Impct of Comorbidities on Time in Therapeutic Range in Patients with Nonvalvular Atrial FibrillationChoi, J. C. / Damaraju, C. / Mills, R. M. / Wildgoose, P. / Fields, L. / Schein, J. / Nelson, W. W. et al. | 2012
- A113
-
PCV13 Comparison of Cardiac Volume Measurements Using Three-Dimensional and Conventional Echocardiography in DogsPoulsen Nautrup, B. / Penzl, S. / Poulsen Nautrup, C. et al. | 2012
- A114
-
PCV18 Evaluation of Response to Loading Doses of Clopidogrel Therapy in Patients Undergoing Percutaneous Coronary Intervention (PCI)Saade, K. / El-hamamsy, M. / Hamdy, M. / Magdy, A. et al. | 2012
- A115
-
PCV23 Prevalence and Incidence of Atrial Fibrillation: An Analysis Based on 8.3 Million PatientsWilke, T. / Groth, A. / Mueller, S. / Verheyen, F. / Linder, R. / Pfannkuche, M. / Maywald, U. / Bauersachs, R. / Breithardt, G. et al. | 2012
- A116
-
PCV29 Missed and Delayed Diagnosis of Stroke in Emergency Department Patients with Headache or DizzinessMoy, E. / Newman-toker, D. E. / Valente, E. / Coffey, R. / Hines, A. L. et al. | 2012
- A117
-
PCV34 Cost and Treatment Duration for Acute Myocardial Infarction in South East AsiaAzmi, S. / Aljunid, S. / Goh, A. / Muhammad nur, A. / Hamzah, S. M. / Ahmed, Z. / Sulong, S. et al. | 2012
- A118
-
PCV39 Determinants of Pharmaceutical Expenditures for Patients with HypertensionCai, B. et al. | 2012
- A119
-
PCV44 Financial Impact of Bleeding Events on Total Knee and Hip Replacements in the Argentinean Health Care SystemCaporale, J. / Aiello, E. / Garay, U. / Lanseros, C. / Waschbusch, M. / Garrido, S. / Alcaraz, A. / Juarez-garcia, A. / Donato, B. M. / Mould, J. F. et al. | 2012
- A120
-
PCV49 Cost-Effectiveness of Cardiac Rehabilitation Program on Patient Medication Adherence and Hospitalization in Medicaid Population with Acute Myocardial InfarctionOu, H. T. / Balkrishnan, R. et al. | 2012
- A121
-
PCV55 Cost-Effectivness of Rosuvastatin Versus Ezetimibe/Simvastatin Fixed Combination in Reaching Cholesterol Goals for Mexican PatientsPolanco, A. C. / Jalon, A. / Rodriguez, I. / Peralta, R. / Ocampo, R. / Lopez-rosas, E. / Cardona, E. et al. | 2012
- A122
-
PCV60 Cost-Utility of Post-Discharge Educational Interventions in Patients with Acute Coronary Syndrome or Chronic Heart FailureCouturier, B. / Carrat, F. / Cohen, A. / Hejblum, G. et al. | 2012
- A123
-
PCV65 Service Utilization, Predictors and Costs among High-Risk Patients with Cardiovascular Disease: Using Real World Data from the Australian Reach RegistryAdemi, Z. / Reid, C. / Bhatt, D. / Steg, P. G. / Liew, D. et al. | 2012
- A126
-
PCV81 Impact of the Awareness of Cardiovascular Disease (CVD) Risk on the Management in Hypertensive Patient in KoreaJeong, M. H. / Kim, D. S. / Chang, H. J. / Park, S. W. / Hong, G. R. / Kim, Y. J. et al. | 2012
- A127
-
PCV86 Comparison of Charlson, Elixhauser and HRQoL-CI Risk Adjustment Measures in Predicting Health-Related Quality of Life in Heart Failure PatientsMehta, H. B. / Aparasu, R. R. / Johnson, M. L. et al. | 2012
- A128
-
PCV91 Development of Methodological Recommendations for Comparative Effectiveness Research on the Treatment of Atrial FibrillationAlavi, R. / Kupferschmidt, B. S. / Spencer, M. R. / Brunner, J. / Desai, P. / Blake, K. / Turkelson, C. et al. | 2012
- A129
-
PCV97 Real World Patient Profile of Patients with Reduced Ejection Fraction Heart Failure (HF-REF) in 5 Regions of ChinaLi, X. Y. / Crawford, B. / Liao, Y. H. / Wang, D. / Sung, J. C. / Zheng, J. / McDonald, J. et al. | 2012
- A130
-
PCV102 Chronic Heart Failure in the Elderly: Costs and Resource Utilization Following Initial HospitalizatonEldar-lissai, A. / Korves, C. / Wei, R. / Sharma, H. / Chen, K. / Ong, S. H. / Duh, M. S. et al. | 2012
- A131
-
PCV107 Impact of Medication Therapy Management (MTM) on Improving Diabetes Care: A Difference-in-Differences ApproachSoliman, A. M. / Brummel, A. R. / Carlson, A. / Oliveira, D. R. / Dowd, B. et al. | 2012
- A132
-
PCV113 Predictors of Receiving and Adhering to Hypertension Therapeutic and Lifestyle Modification ManagementRobles, L. / Bakhireva, L. / Nawarskas, J. J. et al. | 2012
- A133
-
PCV118 Characteristics of Patients Treated with Thienopyridines Following ACS-PCINordstrom, B. / Simeone, J. C. / Zhao, Z. / Molife, C. / Mccollam, P. L. / Ye, X. / Effron, M. B. et al. | 2012
- A134
-
PCV124 Combining Electronic Health Records and Patient-Reported Information in the UK: Preliminary Results from Wasps (Wales Sail + Pro Study)Cascade, E. / Ford, D. / Nixon, M. / Brooks, C. / Heaven, M. et al. | 2012
- A135
-
PGI6 Visualizing Treatment Patterns of Medicare Patients with Crohn'S Disease Who Initiated Tumor Necrosis Factor TherapyBaser, O. / Wang, L. / Xie, L. / Yuce, H. et al. | 2012
- A136
-
PGI11 Economic Evaluation of the Use of Peg-Interferon Alfa 2A in the Treatment of Patients with Chronic Hepatitis C Public Mexican PerspectiveLechuga, D. / Alva, M. et al. | 2012
- A137
-
PGI16 The Direct Economic Burden of Diverticulitis Recurrence among Managed Care EnrolleesYen, L. / Davis, K. L. / Candrilli, S. D. et al. | 2012
- A138
-
PGI21 a Comparison of the Cost-Effectiveness of Fidaxomicin, Metronidazole, and Vancomycin, in the Treatment of Clostridium Difficile-Associated DiseaseMadkour, N. / Bounthavong, M. / Hsu, D. I. et al. | 2012
- A140
-
PND1 A Risk-Benefit Analysis of Natalizumab Across PML Risk Sub-Groups in Patients With Relapsing-Remitting Multiple SclerosisWalker, A. R. / Deniz, B. / Alexopoulos, S. T. / Arnold, R. / Bates, D. et al. | 2012
- A141
-
PND6 Budget Impact Analysis of Antiepileptic Drugs in the Treatment of Lennox-Gastaut SyndromeSkornicki, M. / Clements, K. M. / O'Sullivan, A. K. et al. | 2012
- A142
-
PND11 Cost of Cervical Dystonia in the United StatesBloudek, L. M. / Stacy, M. / Schwartz, M. / Brin, M. / Papapetropoulos, S. et al. | 2012
- A143
-
PND16 Economic Evaluation of Pregabalin and Gabapentin for Neuropathic Pain from the Brazilian Public Health Care System PerspectiveMould, J. F. / Fujii, R. K. / Lazaridis, E. / Manfrin, D. F. et al. | 2012
- A146
-
PND32 Potential Humanistic Benefits of Pegylation in the Treatment of Multiple Sclerosis: A Systematic Review of the LiteratureBecker, R. V. et al. | 2012
- A147
-
PND37 Predictors of Poor Health-Related Quality of Life in Patients With Epilepsy: Insight From the Patientslikeme® Epilepsy Communityde la Loge, C. / Dimova, S. / Mueller, K. / Durgin, T. / Massagli, M. P. / Wicks, P. et al. | 2012
- A148
-
PND42 Burden of Disease in Caregivers of Alzheimer's Disease in Brazil: Results From 2011 National Health and Wellness Survey (NHWS)Mould, J. F. / Fujii, R. K. / Paganini, P. / Manfrin, D. F. et al. | 2012
- A149
-
PND47 Rescue Medication Use in the Acute Treatment of Migraine During Map0004 Pivotal TrialKori, S. / Kellerman, D. / Chen, S. / Lu, B. et al. | 2012
- A150
-
PND52 Determining the Existence of Racial and Ethnic Disparities in Alzheimer's Disease Pharmacotherapy Exposure: An Analysis Across Four State Medicaid PopulationsGilligan, A. / Malone, D. / Warholak, T. L. / Armstrong, E. P. et al. | 2012
- A151
-
PND57 Value-Based Insurance Design in Multiple Sclerosis (MS): Emerging Models and Implications for Development of Real-World DataSnyder, T. / Dobrovolny, D. / Lui, J. / Paas, M. et al. | 2012
- A153
-
PUK8 Nocturia and the Risk of Falls, Fractures, and Sleep Disturbance: a Systematic Review and Meta-AnalysisTsai, K. / Globe, D. / Malone, D. C. et al. | 2012
- A154
-
PUK14 Cost Analysis of Anemia Management in Hemodialysis Patients in 2009: a French Multicenter Retrospective StudyTilleul, P. / Rottembourg, J. / Lafuma, A. / Emery, C. / Zakin, L. / Braunhofer, P. / Mahi, L. / Deray, G. / Wernli, J. et al. | 2012
- A155
-
PUK19 Incremental Cost-Effectiveness of Pharmacist-Managed Erythropoiesis-Stimulating Agents Clinics for Non-Dialysis Chronic Kidney Disease PatientsAspinall, S. L. / Smith, K. J. / Good, C. B. / Zhao, X. / Stone, R. A. / Tonnu-mihara, I. Q. / Cunningham, F. E. et al. | 2012
- A156
-
PUK24 Examining the Role of Caregiver Towards Blood Transfusion Decisions among Individuals with Chronic Kidney DiseaseNaim, A. / Walls, D. / Gollins, J. R. / Reynolds, C. et al. | 2012
- A157
-
PUK29 Erythropoietin-Stimulating Agent (ESA) Dose Recovery Following Hospitalization of End Stage Renal Disease (ESRD) PatientsWang, X. / Bond, T. C. / Rubin, J. L. / Yang, A. et al. | 2012
- A158
-
PUK35 EQ-5D (UK and Thai Preference Weights), SF-6D, and VAS Scores in Dialysis Thai PatientsThaweethamcharoen, T. / Vasuvattakul, S. / Noparatayaporn, P. et al. | 2012
- A159
-
PRM4 Enhancing the Health Economic Value of Retrospective and Prospective Real-World Studies with Pharmacogenomic Testing: Opportunities and Challenges Associated with an Integrated Personalized Medicine ApproachPayne, K. A. / Frueh, F. W. / Sohal, J. et al. | 2012
- A160
-
PRM10 The Behavioral Economics of the Minimally Important DifferenceSuh, J. K. / Doctor, J. et al. | 2012
- A162
-
PRM22 Comparison of Methods for the Evaluation of Ustekinumab Dosing and Costs in Pharmacy Claims DatabasesCarter, C. / Haas, S. / Gunnarsson, C. / Martin, S. et al. | 2012
- A164
-
PRM34 Estimating Markov Chain Transition Matrices in Limited Data Samples: A Monte Carlo ExperimentTsang, K. P. / Wang, B. C. / Garrison, L. et al. | 2012
- A165
-
PRM39 Examination of Starting Point Bias with the Bidding Game: Evidence from a Systematic Review of the Literature on Willingness-to-Pay AnalysesIskedjian, M. / Navarro, V. / Berbari, J. / Lelorier, J. et al. | 2012
- A166
-
PRM44 Pseudo-Randomization in Retrospective Analysis Using the Generalized Multinomial Logit for Propensity Score GenerationWilson, S. M. / Mayne, T. et al. | 2012
- A168
-
PRM57 Cost-Effectiveness Analysis in Personalized Medicine: General Hypotheses and Corresponding Decision Tree Structures for Screening, Diagnostic, Predictive, Prognostic, Surveillance, and Monitoring TestsMladsi, D. M. / Herring, W. L. / Earnshaw, S. R. et al. | 2012
- A169
-
PRM62 Visual Assessment of Fit of Equations to Predict Time-to-Event OutcomesIshak, K. et al. | 2012
- A170
-
PDB3 Risk of Complications in Type II Diabetic Patients With Renal Impairment: an Analysis of the Ramq DatabaseLachaine, J. / Beauchemin, C. / Flavin, J. et al. | 2012
- A171
-
PDB8 the Effect of Dapagliflozin on Hedis Performance Measures of Hba1C in Patients with Type 2 Diabetes MellitusBell, K. / Hardy, E. / De Bruin, T. / Wei, L. / Martin, P. / Ptaszynska, A. et al. | 2012
- A172
-
PDB13 Short Stature in Turner Syndrome: Basal Characteristics and Follow-Up of a Colombian CohortNuñ / ez, S. M. / Arango, A. / Balthazar, V. / Chahin, S. / Duran, P. / Jaimes, G. C. / Manrique, L. A. / Matallana, A. M. / Mejia, L. et al. | 2012
- A174
-
PDB24 Prevalence and Incidence of Type 2 Diabetes Mellitus: An Analysis Based on 5.4 Million PatientsWilke, T. / Groth, A. / Mueller, S. / Ahrendt, P. / Schwartz, D. / Linder, R. / Ahrens, S. / Verheyen, F. et al. | 2012
- A175
-
PDB30 A Comparison of the Costs for Treating Central Precocious Puberty During the First Year With Leuprolide Acetate Injectible and Histrelin Acetate ImplantBanahan, B. F. / Mayo, K. / Summers, K. H. et al. | 2012
- A177
-
PDB41 Impact of Sustained Hemoglobin A1C Control on Health Care Costs Among Patients With Diabetes in HawaiiJuarez, D. / Goo, R. / Tokumaru, S. / Sentell, T. / Davis, J. / Mau, M. et al. | 2012
- A178
-
PDB46 Direct Medical Costs of Treating Diabetes Related Complications in MexicoVega-Herná / ndez, G. / Jugrin, A. / Radford, M. / Bloomfield, E. / Todorova, L. / Hansen, B. et al. | 2012
- A179
-
PDB51 Medication Adherence and Medical Costs Associated With Exenatide Bid Versus Liraglutide: A Retrospective Database AnalysisPelletier, E. M. / Pawaskar, M. / Chapman, R. et al. | 2012
- A180
-
PDB56 Evaluating the Short-Term Cost-Effectiveness of Liraglutide Versus Sitagliptin in Patients With Type 2 Diabetes Failing Metformin MonotherapyLanger, J. / Hunt, B. / Valentine, W. J. et al. | 2012
- A181
-
PDB62 Cost-Effectiveness Modelling of Type-1 DiabetesThokala, P. / Kruger, J. / Brennan, A. et al. | 2012
- A182
-
PDB67 Impact of Adherence to Oral Diabetes Medication on Short-Term Disability Costs in an Employer PopulationWright, D. / Hagen, S. / Finch, R. / Edington, D. et al. | 2012
- A184
-
PDB78 Variation in Attachment Style and Health Outcomes of Diabetes PatientsSansgiry, S. / Naik, A. D. / Brown, A. C. / Latini, D. M. et al. | 2012
- A185
-
PDB83 Diabetes Medication Usage Patterns in Geographies With High Hispanic Populations in the United StatesDockery, J. D. / Smith, D. E. / Navaneetha Krishnan, S. et al. | 2012
- A186
-
PDB88 Impact of Telephone and Mail Intervention on Diabetes Appointment Adherence Rates and Clinical OutcomesJiang, S. / Bamgbade, B. / Barner, J. C. / Klein-Bradham, K. / Janiga, X. / Brown, B. et al. | 2012
- A187
-
PDB93 Impacts of Drug Reimbursement Rate Reductions on Use of Oral Antidiabetic Medications in Taiwan: An Interrupted Time Series StudyHsu, C. S. / Lu, C. Y. / Wagner, A. / Chan, K. W. / Lai, M. S. / Ross-degnan, D. et al. | 2012
- A188
-
PDB98 Treatment Patterns and Treatment Restrictions of Patients With Type II Diabetes Receving Care From Home Health Care Agencies, Skilled Nursing Facilities, and Veterans Affairs Settings in the United StatesGanz, M. L. / Strand, L. / Kongsø / J. H. et al. | 2012
- A189
-
PDB103 Predictors of Hospital Readmissions in Patients With Diabetes: Results From the 1999-2009 Medical Expenditure Panel SurveyDesai, V. C. / Kelton, C. M. / Tundia, N. L. / Heaton, P. C. et al. | 2012
- A190
-
PDB109 Comparative Performance of Comorbidity Measures to Risk-Adjust Health Related Quality of Life in Diabetes PatientsPatel, H. K. / Johnson, M. L. / Aparasu, R. R. et al. | 2012
- A191
-
PIH3 Use of Mixed Treatment Comparison Methods in Estimating Efficacy of Treatments for Heavy Menstrual BleedingHoaglin, D. / Filonenko, A. / Wasiak, R. et al. | 2012
- A192
-
PIH8 Medication Use and Hospital Admission Rates among Preterm Born Infants Compared to Full Term Born InfantsHouweling, L. M. / Bezemer, I. D. / Penning, F. J. / Van Lingen, R. A. / Meijer, W. M. / Herings, R. M. et al. | 2012
- A194
-
PIH19 Impact of Insurance Coverage for in Vitro Fertilization on the Cost Per Live Birth in the USAtzinger, C. B. / Schauer, D. P. / Eckman, M. H. et al. | 2012
- A195
-
PIH24 Modeling the Health and Medical Care Spending of the Future Elderly: An Update Using the Future Elderly ModelLakdawalla, D. / Goldman, D. / Philipson, T. et al. | 2012
- A196
-
PIH29 Adherence among Initiators and Switchers on Generic, Preferred and Non-Preferred Brand TherapiesAverbukh, A. N. / Matlin, O. S. / Chang, A. / Kyrychenko, P. / Fredell, J. W. et al. | 2012
- A197
-
PIH34 Impact of Medicare Part D Coverage Gap on Beneficiaries' Adherence to Prescription MedicationsDesai, U. / Carroll, N. V. et al. | 2012
- A198
-
PIH39 Eliciting Preferences to the EQ-5D-5L Health States: Discrete Choice Experiment or Multiprofile Case of Best-Worst ScalingXie, F. / Pullenayegum, E. / Gaebel, K. / Oppe, M. / Krabbe, P. F. et al. | 2012
- A199
-
PIH45 Satisfaction Assessment of Insurance System for Urban Residents (URMS) of University Students in ShenyangZhang, F. / Du, J. / Li, S. C. et al. | 2012
- A200
-
PIH50 Factor Structure of the Nhanes Physical Function Limitation Questionnaire and its Relationahip with Muscle Measurements in US Elderly Aged 60-80 YearsChen, L. / Naegeli, A. / Watson, P. / Nelson, D. R. / Meldahl, M. L. / Peltz, G. / Zhao, Y. et al. | 2012
- A202
-
PIH61 Burden of Disease in Patients with Menopause in Brazil: Results from 2011 National Health and Wellness Survey (NHWS)Mould, J. F. / Fujii, R. K. / Boulos, F. C. / Manfrin, D. F. et al. | 2012
- A203
-
PIH66 Do we Need a Gender-Specific Health Related Quality of Life –Comorbidity Index?Gupta, P. / Aparasu, R. R. / Johnson, M. et al. | 2012
- A205
-
PIH78 Effect of Hospital Wastes on Drinking Water Quality of KPK Hospitals PakistanBibi Saima Zeb, B. S. / Saira Azhar, D. S. / Qaisar Mahmood, Q. M. et al. | 2012
- A206
-
PIH83 Health Technology Assessment in Child HealthUngar, W. et al. | 2012
- A207
-
PCN3 Relationship Between Comorbidities and Late-Stage Prostate Cancer Diagnosis among Men in FloridaXiao, H. / Tan, F. / Gwede, C. / Goovaerts, P. / Huang, Y. / Ali, A. / Adunlin, G. et al. | 2012
- A208
-
PCN8 Primary Androgen Deprivation Therapy Versus Radical Prostatectomy in Seer-Medicare Dataset: A Comparative Effectiveness Analysis of Retrospective CohortsLiu, J. / Shi, L. / Sartor, O. / Culbertson, R. et al. | 2012
- A209
-
PCN13 Cost-Effectiveness Analysis of Nilotinib Versus Dasatinib in Patients With Imatinib-Resistant or Imatinib-Intolerant Chronic Myeloid Leukemia (CML)Niu, X. / Hay, J. et al. | 2012
- A211
-
PCN25 Effect of Treatments for Late-Stage Prostate Cancer on SurvivalAli, A. A. / Xiao, H. / Adunlin, G. B. et al. | 2012
- A212
-
PCN31 Economic Evaluation of Azacitidine for the Treatment of Myelodysplastic Syndromes (MDS) in the Brazilian Public Health Care System (SUS)Paladini, L. / Pepe, C. / Clark, O. A. / Tencer, T. / Khan, Z. et al. | 2012
- A213
-
PCN36 Epoetin Alfa and Darbepoetin Alfa Dosing Patterns and Costs in Chemotherapy-Induced Anemia InpatientsLafeuille, M. H. / Forlenza, J. B. / Khan, A. / Laliberté / Lefebvre, P. et al. | 2012
- A214
-
PCN41 Economic Burden Associated With Adverse Events in Patients With Metastatic Renal Cell CarcinomaBorker, R. D. / Knapton, L. M. et al. | 2012
- A217
-
PCN57 Cost Effectiveness of Nilotinib Versus Imatinib as First Line Treatment for Newly Diagnosed Hong Kong (HK) Patients With Chronic Phase, Philadelphia Chromosome-Positive (PH+) Chronic Myeloid Leukemia in the Chronic Phase (CML-CP) in Hong KongTse, V. / Liu, H. / Botteman, M. / Mcghee, S. / Lee, V. W. / Lee, K. K. et al. | 2012
- A219
-
PCN67 Cost Effectiveness of Zoledronic Acid (ZOL) in Postmenopausal Women With Early Breast Cancer Receiving Adjuvant Letrozole From German and Italian PerspectivesXue, M. / Fishman, P. / Botteman, M. et al. | 2012
- A220
-
PCN72 Cost Effectiveness Analysis of New Treatments for Metastatic Castration-Resistant Prostate Cancer: Does Severity Matter?Wilson, L. S. / Zhong, L. / Pon, V. / Srinivas, S. / Frear, M. / Nguyen, N. / Gong, C. / Kwon, S. / Malmstrom, R. / Loucks, A. et al. | 2012
- A221
-
PCN78 The Cost-Effectiveness of Temozolomide in the Adjuvant Treatment of Newly Diagnosed Glioblastoma in the United StatesMessali, A. / Hay, J. / Villacorta, R. et al. | 2012
- A222
-
PCN84 Economic Evaluation of the Use of Capecitabine as First-Line Treatment of Metastatic Colorectal Cancer in MexicoLechuga, D. / Alva, M. / Leyva, V. / Salinas, G. E. et al. | 2012
- A223
-
PCN89 Economic Evaluation of Erlotinib as Treatment of or Metastasic Cancer of Non-Small Cell Lung Cancer (NSCLC) Prior Chemotherapy in MexicoLechuga, D. / Alva, M. / Sanchez-Kobashi, R. / Gay, J. G. et al. | 2012
- A224
-
PCN95 Using a Condition-Specific Measure of Patient-Reported Outcomes to Derive Utilities in MyelofibrosisRoskell, N. S. / Mendelson, E. T. / Whalley, D. / Knight, C. et al. | 2012
- A226
-
PCN106 Development of a Guidance for Including Patient-Reported Outcomes (PROs) in Late-Phase Adult Clinical Trials of Oncology Drugs for Comparative Effectiveness Research (CER)Basch, E. M. / Abernethy, A. P. / Mullins, C. D. / Spencer, M. R. et al. | 2012
- A227
-
PCN111 Evaluating Meaningful Change on the Lung Cancer Symptom Scale in Small Cell Lung Cancer: Results From a Phase III Clinical TrialO' / Brien, M. / Hudgens, S. / King, J. / McNally, R. / Khan, Z. et al. | 2012
- A228
-
PCN116 Using the Modified RAND/UCLA Delphi Process to Produce Treatment Consensus in Unresectable Midgut Gastrointestinal Neuroendocrine TumorsStrosberg, J. R. / Fisher, G. / Benson, A. B. / Malin, J. L. / Anthony, L. / Arslan, B. / Gibbs, J. F. / Greeno, E. / Iyer, R. / Kim, M. K. et al. | 2012
- A229
-
PCN121 Evaluation of Aromatase Inhibitor Utilization and Failure in Post-Menopausal Women With Advanced ER+/HER2- Breast CancerLandsman-Blumberg, P. / Namjoshi, M. / Thomson, E. / Johnson, W. et al. | 2012
- A230
-
PCN126 Radiation After Breast-Conserving Surgery: Compliance of Clinical Guideline Among Young Women With Employment-Based Insurance in the United StatesPan, I. W. / Smith, B. D. / Shih, Y. C. et al. | 2012
- A231
-
PCN131 Patients' Out-of-Pocket (OOP) Costs for Granulocyte Colony-Stimulating Factors (G-CSF)Tomic, K. S. / Long, S. / Li, X. / Yu, J. / Fu, A. C. / Barron, R. et al. | 2012
- A232
-
PCN137 Surgery, Radiation, and Systemic Therapies in Patients With Metastatic MelanomaWang, S. / Zhao, Z. / Barber, B. / Wagner, V. et al. | 2012
- A233
-
PCN142 Association of Health-Related Quality of Life Among Patients With Multiple Myeloma With Insurance CoveragePashos, C. L. / Durie, B. G. / Rifkin, R. M. / Abonour, R. / Fonseca, R. / Gasparetto, C. / Mehta, J. / Narang, M. / Shah, J. J. / Terebelo, H. R. et al. | 2012
- A234
-
PCN147 Evaluating Contemporary Practice in Cml via a Retrospective Research Registry of Patients Across a Comprehensive Cancer Center DatabaseStenehjem, D. / Albright, F. / Kuo, K. L. / Raimundo, K. / Brixner, D. et al. | 2012
- A235
-
PCN154 Challenges Posed by Patient Crossover for Cost-Effectiveness Analysis of Oncology Products: A Case Study in Metastatic Pancreatic CancerGrima, D. T. / Brown, S. T. / Attard, C. L. / Duong, M. T. et al. | 2012
- A236
-
PIN1 Outcomes Associated With Severe Comorbidities in Hospitalized Cases of HIV/AIDSVilla, L. / Skrepnek, G. et al. | 2012
- A237
-
PIN6 Evaluation of the Clinical and Economic Burden of the Human Immunodeficiency Virus in Veteran Patients in the United StatesBaser, O. / Wang, L. et al. | 2012
- A238
-
PIN11 Costs of Adverse Events Among Patients With Human Immunodeficiency Virus Treated With Non-Nucleoside Reverse Transcriptase InhibitorsSimpson, K. N. / Chen, S. Y. / Wu, A. / Boulanger, L. / Khachatryan, A. / Chambers, R. / Tawadrous, M. / Pashos, C. L. / Haider, S. et al. | 2012
- A239
-
PIN17 Cost of Treatment Failure Among Adult Outpatients With Moderate or Complicated Community-Acquired Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) Skin Infections: A Starnet StudyLabreche, M. J. / Lee, G. / Mortensen, E. M. / Dallas, S. D. / Du, L. C. / Nyren, N. R. / Pena, J. / Rocha, G. / Esparza, S. / Finnie, M. et al. | 2012
- A240
-
PIN22 Economic Burden of Hospitalization With Antibiotic Treatment for Absssi in the United States: An Analysis Ofthe Premier Hospital DatabaseLaPensee, K. T. / Fan, W. / Wang, Y. et al. | 2012
- A241
-
PIN27 The Cost-Effectiveness of Telaprevir (TVR) in Combination With Pegylated Interferon-Alfa and Ribavirin (PR) for the Treatment of Genotype 1(G1) Chronic Hepatitis C PatientsCure, S. / Curtis, S. / Bianic, F. / Gavart, S. / Dearden, L. / Fleischmann, J. / Ouwens, M. / Lee, S. et al. | 2012
- A242
-
PIN32 Cost-Effectiveness Analysis of Tigecicline in the Treatment of Complicated Intra-Abdominal Infection in MexicoTellez-Giró / n, G. / Soto-Molina, H. / Rizzoli-Có / rdova, A. / Dí / az-Ponce, H. / Galindo-Suá / rez, R. M. et al. | 2012
- A243
-
PIN37 Cost-Effectiveness of Treatment Initiation With Ritonavir-Boosted Atazanavir (ATV/R) and Lopinavir (LPV/R) in Treatment-NaÏve HIV Patients at Different CD4 Levels at BaselineVerheggen, B. / Aldir, I. / Tan, C. / Carrasco, J. / Antunes, A. / Lescrauwaet, B. et al. | 2012
- A244
-
PIN42 The Cost-Effectiveness of Telaprevir (TVR) in Combination With Pegylated Interferon-Alfa and Ribavirin (PR) for the Treatment of Genotype 1(G1) Chronic Hepatitis C Patients: A Post-Hoc Analysis of Il-28B SubgroupCurtis, S. / Cure, S. / Bianic, F. / Gavart, S. / Dearden, L. / Fleischmann, J. / Ouwens, M. / Lee, S. et al. | 2012
- A245
-
PIN47 The Humanistic and Economic Burden of Hepatitis C Across the United States, Europe, and AsiaDiBonaventura, M. D. / Yuan, Y. / Lescrauwaet, B. / L'Italien, G. / Liu, G. G. / Kamae, I. / Mauskopf, J. A. et al. | 2012
- A246
-
PIN54 Access to Medication for Uninsured Individuals Living with HIV/AIDS in the United StatesWolfe, R. / Weinlein, M. / Rizzo, M. et al. | 2012
- A247
-
PIN59 Assessing the Awareness About Human Papillomavirus (HPV) and Attitude Towards the Hpv Vaccine in a Cohort of Male College StudentsMedhekar, R. A. / Hatfield, M. D. / Sansgiry, S. S. et al. | 2012
- A248
-
PIN64 Burden of Pneumococcal Infection in Adults in ColombiaRosselli, D. / Rueda, J. D. et al. | 2012
- A249
-
PSS1 Relieving the Pruritus of Atopic Dermatitis: A Meta-AnalysisSher, L. / Chang, J. / Patel, I. / Balkrishnan, R. / Fleischer, A. B. et al. | 2012
- A251
-
PSS12 Economic Analysis of Etanercept as Continuous or Paused Therapy in Moderate to Severe Psoriasis from a Public Perspective in VenezuelaFernandes, R. A. / Takemoto, M. L. / Amaral, L. M. / Cruz, R. B. / Mould, J. F. / Rodriguez, J. C. et al. | 2012
- A253
-
PSS22 A Comprehensive Health Impact Assessment and Determinants of Quality of Life, Health and Psychological Status in Acne PatientsPagliarello, C. / di Pietro, C. / Tabolli, S. et al. | 2012
- A254
-
PSS27 Relationship Between Weight and Dose in Psoriasis Patients Treated with UstekinumabSchmeichel-Mueller, C. / Goren, A. / DiBonaventura, M. D. / Martin, S. et al. | 2012
- A255
-
PSS32 Pharmacoeconomic Evaluation of Bacterial Eye Inflammation Treatment in RussiaSerpik, V. G. / Yagudina, R. et al. | 2012
- A257
-
ISPOR 17th Annual International Meeting Financial Disclosure Information for Research Presentations| 2012
- A266
-
ISPOR 17th Annual International Meeting Research Abstracts Author Index| 2012
- i
-
Table of Contents| 2012
- I
-
Guide for Authors| 2012
-
CV3 Comparative Effectiveness of Statins in a Large Managed Care Organization: Cardiovascular Event Rate and Total Health Care CostWang, J. J. / White, T. J. / Fisher, V. S. / Devries, A. / Mcneeley, B. / Abarca, J. et al. | 2012
-
DR4 Clarity, Consistency and Transparency in Decision-Making: Testing a Novel P&T Framework for Assessing EvidenceGraff, J. / Dean, B. / Ko, K. / Localio, A. R. / Dubois, R. W. et al. | 2012
-
HC3 Assessing the Value of Biopharmaceuticals: Cost-Effective Innovations or Inefficient Use of Resources?Wilson, A. / Neumann, P. J. et al. | 2012
-
PR4 Breast Cancer Mortality Rates by Geographic Region, Years of Potential Life Lost, and Value of Productivity Losses among Women Aged 20-49 Years in the United States, 1970–2008Ekwueme, D. U. / Guy, G. P. / Rim, S. H. / Hall, I. J. / Thomas, C. C. / Fairley, T. L. / Rodriguez, J. / White, A. et al. | 2012
-
QU3 Psychometrics of the Actinic Keratosis Risk Questionnaire: A Risk Assessment InstrumentBalkrishnan, R. / Kulkarni, A. S. / Gatwood, J. / Anderson, R. T. / Narahari, S. / Landis, E. / Feldman, S. R. et al. | 2012
-
PHP4 Health Literacy and its Impact on National Health Care UtilizationAgbor Bawa, W. / Rasu, R. et al. | 2012
-
PHP9 Consensus-Based Policy Solutions for Medicines Adherence for Europe: Development and EvaluationClyne, W. / White, S. / McLachlan, S. et al. | 2012
-
PHP37 Are Hospital Inpatient Costs Lower for Medicare Advantage Enrollees Than Medicare Fee-for-Service Beneficiaries?Karaca, Z. / Wong, H. et al. | 2012
-
PHP41 One-Year Assessment of Joint Procurement of Pharmaceuticals in the Public Health Sector in JordanAlabbadi, I. / Qawwas, A. / Jaafreh, M. / Abosamen, T. / Saket, M. et al. | 2012
-
PHP44 International Comparison of Pharmaceutical Expenditure in Middle Income Countries: Methodological QuestionsKalo, Z. / Inotai, A. / Meré / sz, G. et al. | 2012
-
PHP57 An Analysis of Intravenous Medication Errors Using Incident Reports at a Teaching Hospital in JapanTsuda, Y. / Hirose, M. / Egami, K. / Ohama, K. / Honda, J. / Shima, H. et al. | 2012
-
PHP63 Economic, Clinical and Humanistic Outcomes of a Collaborative Pharmacist- Physician Medication Therapy Management Service for Polypharmacy ElderlyLin, H. W. / Lin, C. H. / Chang, C. K. / Yu, I. W. / Lin, C. C. / Li, T. C. / Li, C. I. / Hung, J. S. et al. | 2012
-
PHP69 Trends of Emergency Room Visits Versus Hospitalizations Due to Unintentional Poisonings in Kansas City, MissouriLiu, Y. / Cai, J. / Hong, L. / Hoff, G. L. / Okah, F. A. et al. | 2012
-
PHP82 Comparative Analysis of Diseases Prevalence Rates in General Ukrainian Population and Subpopulations of War Veterans and Chernobyl VictimsBocharova, V. / Zalis' / ka, O. / Tolubaiev, V. / Majnych, J. et al. | 2012
-
PHP98 The Future of Alternative Pricing/Risk-Sharing Agreements in the United StatesGoldenberg, D. / Bachman, E. M. et al. | 2012
-
PHP99 How to Deal With Decision Uncertainty? The Italian Experience With Managed Entry AgreementsSiviero, P. D. / Sammarco, A. / Tafuri, G. / Pani, L. et al. | 2012
-
PMS5 Data Visualization of Treatment Patterns of Medicare Psoriatic Arthritis Patients Who Initiate Tumor Necrosis Factor TherapyBaser, O. / Wang, L. / Xie, L. / Yuce, H. et al. | 2012
-
PGI9 Impact of Switching Patients from Twice Daily Proton Pump Inhibitors to Once Daily DexlansoprazoleParthan, A. / Mody, R. R. / Deflin, M. M. / Akhras, K. S. et al. | 2012
-
PGI15 The Economic Burden of Unmet Treatment Needs in Medicaid Patients with Chronic ConstipationCarson, R. T. / Guerin, A. / Lewis, B. / Yin, D. / Kaminsky, M. / Ramakrishnan, K. / Wu, E. Q. et al. | 2012
-
PGI17 Societal Burden in Patients with Liver Transplantation: The Come Study ResultsFusco, F. / Scalone, L. / Fagiuoli, S. / Ciampichini, R. / Gaeta, L. / Del prete, A. / Gardini, I. / Mantovani, L. G. et al. | 2012
-
PGI22 Cost-Effectiveness Analysis of Proton Pump Inhibitors for Treatment of Severe Gastroesophageal Reflux Disease in MexicoPozo Urquizo, L. / Latapi, E. / Soto Molina, H. / Polanco, A. C. et al. | 2012
-
PGI26 Resource Utilization and Costs Associated with Diverticulitis Inpatient Admissions: An Analysis of the Economic Burden of DiverticulitisSpiegel, B. / Poysophon, P. / Snyder, B. / Agarwal, N. / Yen, L. / Hodgkins, P. / Cohen, E. / Vu, M. / Kurzbard, N. / Atia, M. et al. | 2012
-
PND25 The Role of Structural Sensitivity Analysis in the Modelling of Cost-Effectiveness (Cost-Utility) in Parkinson's Disease in the United States and United KingdomRatcliffe, A. E. et al. | 2012
-
PND40 Assessment of Dementia Risk Among Caregivers of Alzheimer's Care RecipientsMajethia, U. / Nayak, R. et al. | 2012
-
PND41 Parkinson's Disease Questionnaire (PDQ-39) As a Primary Endpoint in a Trial Comparing Deep Brain Stimulation With Best Medical Therapy Versus Best Medical Therapy Alone for Advanced Parkinson's Disease (PD SURG TRIAL): A Randomised, Open-Label TrialJenkinson, C. / Williams, A. / Ives, N. / Rick, C. / Daniels, J. / Patel, S. / Wheatley, K. / Churchman, D. et al. | 2012
-
PND48 Real World Treatment Profile of Patients With Tuberous Sclerosis ComplexSun, P. / Liu, Z. / Kohrman, M. et al. | 2012
-
PUK5 a Systematic Review and Meta-Analysis of Solifenacin Succinate Versus Trospium Chloride for Overactive BladderOdeyemi, A. / Hart, W. M. / Nazir, J. et al. | 2012
-
PUK15 a Managed Care Cost-Offset Model for Ferric Citrate, an Experimental Phosphate Binder That Can Reduce the Use of Erythropoiesis-Stimulating Agents and Intravenous Iron in Hemodialysis Patients with HyperphosphatemiaMutell, R. / Rubin, J. L. / Bond, T. C. / Mayne, T. et al. | 2012
-
PRM18 Review of Administration's Cost Assumption of Rotavirus and Pneumococcal Vaccines Cost-Effectiveness AnalysesDe la Hoz-Restrepo, F. / Castañ / eda-Orjuela, C. A. / Alvis, N. / Paternina, A. et al. | 2012
-
PRM20 Comparing the Use of Secondary Data Sources in Two Types of Journals During 2010Akridge, J. / Zreikat, H. H. / Harpe, S. E. et al. | 2012
-
PRM65 Prevalence-Based Versus Incidence-Based Economic Evaluations for the Assessment of New Health Care InterventionsMauskopf, J. A. et al. | 2012
-
PDB19 A Comparison of Standards of Diabetes Care Across Different Racial/Ethnic Groups in the United States Non-Institutionalized Adult Population: A Study Using the 2009-2010 Nhanes CohortPerez, A. / Quansah, K. A. / Sanchez, J. et al. | 2012
-
PDB29 Budget Impact Analysis of Norditropin Versus Three Leading Market Growth Hormone TherapiesSolem, C. T. / Smith, C. / Wiegand, P. / Botteman, M. / Germak, J. / Wisniewski, T. et al. | 2012
-
PDB42 Health Care Resources Utilization and Cost for Hypoglycemia and Metabolic Acidosis in Type Ii Diabetes: an Analysis of the Ramq DatabaseLachaine, J. / Beauchemin, C. / Flavin, J. et al. | 2012
-
PDB45 Direct Medical Costs of Diabetes-Related Complications in Saudi ArabiaHnoosh, A. / Vega-Herná / ndez, G. / Jugrin, A. / Todorova, L. et al. | 2012
-
PDB100 Health Care Utilization and Cost Patterns Among Diabetes Patients Prior to Initiation With Saxagliptin and Other (Non-Insulin) Antidiabetic Medications in a US Health PlanWilliams, S. / Thayer, S. / Fan, Y. / Parasuraman, S. et al. | 2012
-
PDB104 Economic and Clinical Analysis of a Medication Management Program Targeting Patients With Uncontrolled Diabetes: A Two-Year AnalysisSuh, K. / Prasla, K. / Gorsh, B. / Tabor, T. / Godley, P. J. / Chaddick, J. et al. | 2012
-
PDB107 Patient Characteristics and Outcomes Among Individuals With Type 2 Diabetes: A Comparison Based Upon AdherenceEby, E. / Lage, M. / Mitchell, B. et al. | 2012
-
PIH5 Systematic Review Comparing the Efficacy of the 5-Alpha Reductase Inhibitors (5-Aris) Dutasteride and Finasteride in the Treatment of Benign Prostatic Hyperplasia (BPH)Conte, T. / Truzzi, J. C. / Tannus, G. / Fonseca, M. et al. | 2012
-
PIH7 Risk of All-Cause Hospitalization in Dual Eligible Beneficiaries Using Antipsychotic AgentsAparasu, R. R. / Chatterjee, S. et al. | 2012
-
PIH15 Application of Probabilistic Linkage: Compare Health Care Costs among Menopausal Women with Different Symptoms by Linking Women's Registry and Claims DatabaseBaser, O. / Xie, L. / Du, J. / Smith, Y. et al. | 2012
-
PIH38 The Relative Influence of Perceived Need for Medications Versus Perceived Medication Concerns in Determining Medication Adherence: Narrative Systematic Review and Meta-AnalysisZhang, N. J. / McHorney, C. et al. | 2012
-
PIH57 Application of the Bother Concept Across CulturesGawlicki, M. C. / Mckown, S. / Talbert, M. / Brandt, B. A. et al. | 2012
-
PIH62 Over-the-Counter Medication Use and its Impact on Quality of Life of the ElderlyMhatre, S. / Sansgiry, S. et al. | 2012
-
PIH65 Psychometric Validation of the Tummy Tuck QuestionnaireAbrams, S. / Hudgens, S. / Banderas, B. / Krishnan, S. / Ito, D. / Li-McLeod, J. et al. | 2012
-
PIH69 Willingness to Pay for Vasomotor Symptoms Treatment in KoreaSon, M. J. / Park, H. J. / Ko, S. K. et al. | 2012
-
PIH70 Is Primary Care Accessible for the Poor in Mongolia?Chimeddamba, O. et al. | 2012
-
PCN26 A Budget Impact Analysis of Vinorelbine Introduction on Croatian Positive Drugs List in Breast Cancer TreatmentVitezic, D. / Hadzic-Kostrencic, C. / Petkovic, M. / Mrsic Pelcic, J. et al. | 2012
-
PCN33 Indirect Analysis of the Efficacy and Safety of Pemetrexed/Cisplatin Compared With Bevacizumab/Gemcitabine/Cisplatin as First-Line Treatment for Advanced, Non-Squamous Non-Small Cell Lung Cancer and Associated Treatment Costs in the Private Mexican Health Care SystemRamirez Gamez, J. / Cruz Cadena, A. / Davey, P. / Rajan, N. / Barraclough, H. / Orlando, M. et al. | 2012
-
PCN48 Costs Associated to Treatment of Metastatic HER2 Positive Breast Cancer After Progression to Trastuzumab Under the Perspective of the Brazilian Private Health Care SystemClark, O. A. / Teich, V. et al. | 2012
-
PCN63 Addition of Bivalent or Quadrivalent HPV Vaccines to Cervical Cancer Screening, in Colombia. A Cost- Effectiveness AnalysisAponte, J. / Eslava-Schmalbach, J. / Gamboa, O. / Fajardo, L. et al. | 2012
-
PCN66 Economic Evaluation of Abiraterone Acetate as Treatment for Metastatic Castration Resistant Prostate Cancer After Failure of Docetaxel in SwedenPersson, U. / Nilsson, S. / Hjortsberg, C. / Prû / tz, C. et al. | 2012
-
PCN98 The Development of an Internationally-Valid Cancer-Specific Multi-Attribute Utility Instrument (MAUI) From the Eortc Core Health-Related Quality of Life (HRQOL) Questionnaire, QLQ-C30King, M. / Costa, D. S. / Aaronson, N. K. / Brazier, J. / Cella, D. F. / Fayers, P. / Pallant, J. F. / Peacock, S. / Pickard, A. S. / Rowen, D. et al. | 2012
-
PCN105 Patient-Reported Outcomes (PROs) and Tolerability of Therapeutic Agents in Patients With Metastatic Prostate Cancer (MPC): A Systematic Literature ReviewSeal, B. / Puto, K. / Allen, P. D. / Asche, C. V. et al. | 2012
-
PCN145 Treatment Patterns and Outcomes Among Patients With Unresectable Stage III or Stage IV Melanoma in MexicoSilva, A. / Lá / zaro-Leó / n, M. / de la peñ / a, R. / Frausto, P. / Vargas-Valencia, J. J. / Gó / mez-Roel, X. et al. | 2012
-
PIN2 Safety and Efficacy of RV1 and RV5 Rotavirus VaccinesBergman, H. / Soares-weiser, K. / Maclehose, H. / Cunliffe, N. / Garner, P. et al. | 2012
-
PIN4 Efficacy and Safety of the Combination Tenofovir (TDF)/Emtricitabina (FTC) + Efavirenz (EFV) in Treatment of Naive Adult Patients With HIV-1 Infection: A Systematic ReviewRizzoli, A. / Vargas, G. / Pizarro, M. / Soto Molina, H. et al. | 2012
-
PIN12 Cost Analysis of Rilpivirine Versus Efavirenz for Treatment of Human Immunodeficiency Virus (HIV)Parrett, J. / Dikun, J. / Datar, M. / Yang, Y. et al. | 2012
-
PIN15 Impact of Surgical Staphylococcus Aureus Infections on US HospitalsYu, H. / Mardekian, J. / Siu, G. / Zito, E. / Girgenti, D. et al. | 2012
-
PIN29 Cost Effectiveness Analysis of Addition of Telaprevir or Boceprevir to Standard Therapy Versus Standard Therapy Alone for the Treatment of Previously Untreated Chronic Hepatitis-C Virus Genotype 1 InfectionRamachandran, S. / Mahabaleshwarkar, R. / Yang, Y. et al. | 2012
-
PSS5 Assessment of the Demand and the Financial Impact of the Isotretinoin in Specialized Component of Pharmaceutical Services (CEAF) in 2011, Minas Gerais (MG), BrazilFigueiredo, A. C. / Souza, K. M. / Villela, E. / Silva, L. / Oliveira, J. / Machado, T. / Souza, A. L. / Garcia, M. / Pereira, V. et al. | 2012
-
PSS33 Comparison of the Skindex-17 Quality of Life Questionnaire with the Skindex-29 in a Large Sample of Dermatological OutpatientsSampogna, F. / Spagnoli, A. / Di Pietro, C. / Pagliarello, C. / Paradisi, A. / Tabolli, S. / Abeni, D. et al. | 2012
-
PSS30 Dosing Patterns and Health Care Provider Interactions for Psoriasis Patients Treated with UstekinumabCarter, C. / Martin, S. / Smith, D. et al. | 2012
-
PMS15 Cost Analysis of Febuxostat Versus Allopurinol for Prophylaxis of Gout FlaresJackson, T. / Shah, R. et al. | 2012
-
PMS16 Cost of Tumor Necrosis Factor Blocker Per Treated Psoriatic Arthritis Patient Using Drug Utilization Data from a US Managed Care PopulationBonafede, M. / Watson, C. / Gandra, S. R. / Princic, N. / Fox, K. M. et al. | 2012
-
PMS21 Mapping Health Care Costs to Clinical Disease Activity Where Cost Data is Lacking – A Novel Approach Using Medical Expenditure Panel Survey Data with the Corrona Rheumatoid Arthritis Disease RegistryIngham, M. / Ghushchyan, V. H. / Reed, G. / Decktor, D. / Bolce, R. / Bolge, S. / Nair, K. V. et al. | 2012
-
PMS23 Cost Per Treated Rheumatoid Arthritis (RA) Patient for Etanercept, Adalimumab and Infliximab: A Retrospective Claims Database AnalysisBonafede, M. / Gandra, S. R. / Watson, C. / Princic, N. / Fox, K. M. et al. | 2012
-
PMS42 Observed Dosing and Refill Compliance in Psoriatic Arthritis Patients Treated with GolimumabEllis, L. / Haas, S. / Tandon, N. et al. | 2012
-
PMS43 Intentional and Unintentional Non-Adherence and Patient Characteristics Associated with Treatment in Rheumatoid Arthritis PatientsGoren, A. / Vietri, J. / Madi, O. et al. | 2012
-
PMS52 Validation of Remission of Rheumatoid Arthritis by Traditional Disease Activity Score and Provisional Criteria by American College of Rheumatology and European League Agaisnt Rheumatism: Analysis Based on Patient Reported Outcomes from 3 Phase III Clinical Trials of GolimumabHan, C. / Keystone, E. / Fleischmann, R. / Smolen, J. S. / Emery, P. / Genovese, M. / Doyle, M. / Hsia, E. et al. | 2012
-
PMS73 A Systematic Literature Review of Economic Studies and a Cost Analysis Related to Epidural Steroid Injections in the ElderlyBresnahan, B. / Rundell, S. / Friedly, J. / Jarvik, J. / Sullivan, S. D. et al. | 2012
-
PMS74 Developing and Implementing Patient-Resource Use Diaries for a Clinical Trial Assessing Spinal Stenosis Interventions in the ElderlyBresnahan, B. W. / Rundell, S. / Comstock, B. / Sullivan, S. D. / Jarvik, J. G. / Nguyen, H. / Bauer, Z. / Friedly, J. et al. | 2012
-
PMS75 Annual Golimumab Utilization and Costs for Psoriatic Arthritis Patients Enrolled in Managed Care PlansCarter, C. / Smith, D. / Tandon, N. et al. | 2012
-
PMS79 Patient Characteristics and Golimumab Utilization in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis PatientsTandon, N. / Haas, S. / Bolge, S. / Gunnarsson, C. et al. | 2012
-
PRS9 Waterpipe Smoking among University Students in the United States: Predictors of an Intention to QuitWu, I. H. / Rajan, S. S. / Peters, R. J. / Essien, E. J. / Abughosh, S. et al. | 2012
-
PRS33 The Effect of Adherence to Combination Therapy of Long Acting Beta Agonist and Inhaled Corticosteroid (Laba + Ics) on Emergency Department (Ed) Utilization in Newly Diagnosed Asthma PatientsChung, J. / Nichol, M. B. et al. | 2012
-
PMD7 Long-Term Clinical Outcomes After Coronary Bare-Metal and Drug-Eluting StentingYin, S. / Parente, A. K. / Teigland, C. / Jones, B. T. / Wang, R. H. et al. | 2012
-
PMD57 New Approaches for Graphing Probabilistic Patient-Relevant Health Outcomes: The Case of Renal Denervation for Resistant HypertensionGeisler, B. P. / Cohen, J. T. / Neumann, P. J. / Pietzsch, J. B. et al. | 2012
-
PSU4 Open Versus Endovascular Repair for Abdominal Aortic Aneurysm: An Exploration with Discharge and Post-Discharge-Mortality DataMark, T. / Steiner, C. / Lawrence, W. / Coffey, R. / Chu, B. C. / Kenney, T. / Nagamine, M. / Zheng, D. et al. | 2012
-
PSU16 Retrospective Analysis of Cost Outcomes for Patients Receiving Infuse Bone Graft (rhBMP-2) or Actifuse Bone Graft Substitute (Si-CaP) During Posterolateral Spinal FusionMagee, G. / Boatright, A. / Hagerman, E. / Baumer, D. / Krishnan, S. et al. | 2012
-
PSU39 Identification of Bariatric Surgical Procedures, Comorbidities and Adverse Events in Payor DataHatoum, I. J. / Hunter, T. D. / Francis, D. M. / Steinbuch, M. / Kaplan, L. M. et al. | 2012
-
PMH31 The Cost of a Schizophrenia Relapse in the Brazilian Private Health Care SystemBahmdouni, L. S. / Pereira, M. L. / Ferreira, C. N. / Santana, C. F. / Salles, G. R. et al. | 2012
-
PMH32 Impact of Second Generation Anti-Psychotics in Bipolar Patients and Schizophrenia Patients in Th California Medicaid ProgramMcCombs, J. / Jiang, Y. et al. | 2012
-
PMH75 Utilization of Prescription Sedative Hypnotics in Patients with and Without Insomnia DiagnosisWallace, L. E. / Kadakia, A. et al. | 2012
-
PSY3 Adverse Events Associated With Anti-TNF-Alpha- Agents: A Pharmacovigilance StudyDahlquist, J. E. / Guo, J. J. / Sietsema, W. / Sarangdhar, M. / Wigle, P. / Aronow, B. et al. | 2012
-
PSY20 Costs Associated With the Burden of Joint Pain in Hemophilia A and B Patients With and Without InhibitorsCyaniuk, A. / Smith, C. / Upadhyay, A. / Swallow, E. / Cooper, D. / Wisniewski, T. et al. | 2012
-
PSY31 Economic Evaluation of Eletriptan 40mg for Migraine Therapy in KoreaKim, H. J. / Oh, J. J. / Park, H. J. / Ko, S. K. et al. | 2012
-
PSY36 Economic Evaluation of Pegvisomant for Active Acromegaly Patients who Failed Available Therapies in Brazil – Public Health Care System PerspectiveFujii, R. K. / Mould, J. F. / Fernandes, R. A. / Furlan, F. / Manfrin, D. F. et al. | 2012
-
PSY51 Use of Narcotic Medications Among a Large Commercially-Insured Population in the United StatesTian, Y. / Henderson, R. R. / Frazee, S. G. et al. | 2012
-
PSY67 Psychometric Validation of the Pain Impact Questionnaire Revised With a 1-Week RecallMiller, K. / Smith, K. J. et al. | 2012
-
PCV17 Association of Adherence to Colesevelam HCI and Risk of Major Cardiovascular EventsYe, X. / Qian, C. / Li, T. et al. | 2012
-
PCV40 Evaluating Health Care Utiliization and Costs Associated with Blood Pressure Control in Patients with Newly Treated HypertensionCheng, I. N. / Flicker, W. / Shinmoto, M. / Pulicharam veettil, J. / Wong, K. et al. | 2012
-
PCV46 Assessing the Cost-Effectiveness of the Recommended Antihypertensive Drug Classes in France Using a Lifetime Markov ModelGerlier, L. / Midy, F. / Liè / vre, M. / Cohn, E. / Vellopoulou, K. / Maurel, F. / Lamotte, M. et al. | 2012
-
PCV53 A Cost-Effectiveness Analysis Comparing Dabigatran and Standard Treatment for Stroke Prevention in Atrial Fibrillation in SlovakiaPsenkova, M. / Mackovicova, S. / Tomek, D. / Bielik, J. / Spitzerova, H. et al. | 2012
-
PCV59 Cost-Effectiveness of Dabigatran Etexilate Versus Apirin Plus Clopidogrel Combination in Stroke Prevention in Atrial Fibrillation (SPAF): Russian Payer PerspectiveBelousov, Y. B. / Mareev, V. Y. / Belousov, D. Y. / Afanasieva, E. V. / Ashikhmin, Y. I. / Ustyugova, A. V. et al. | 2012
-
PCV64 Health Care Resource Utilization and Costs for Acromegaly: A Retrospective Study in a Large Claims Database in the United StatesBurton, T. M. / Le nestour, E. / Bancroft, T. / Di donato, F. A. / Neary, M. et al. | 2012
-
PCV82 the Burden: A New Approach to Evaluating Venous InsufficiencyTaieb, C. et al. | 2012
-
PCV84 A Comparison of Clinician and Patient Views on Symptoms and Impact of Post-Stroke SpasticityAtkinson, M. J. / Gillard, P. / Dunning, K. / D' / Ambrosio, L. / Varon, S. F. / Zorowitz, R. D. / Kissela, B. et al. | 2012
-
PCV85 Effect of Secondary Preventive Measures on the Health Related Quality of Life of Myocardial Infarction PatientsShah, J. / Aparasu, R. R. / Birtcher, K. K. / Johnson, M. L. et al. | 2012
-
PCV87 Impact of an Interactive Care Plan on Patient Activation in Heart Failure InpatientsComer, D. / Wright, D. / Southerton, J. / Couto, J. et al. | 2012
-
MO4 Economic Evaluation of Treatment Strategies for Late-Presentation Acute Ischemic StrokeNam, J. / O'Reilly, D. et al. | 2012
-
HC1 Did Massachusetts Health Reform Lower Hospital Inpatient Cost?Wong, H. / Karaca, Z. et al. | 2012
-
PHP3 Value-Based Design and Prescribing PatternsGibson, T. B. / Mahoney, J. / Lucas, K. / Heithoff, K. / Gatwood, J. et al. | 2012
-
PHP7 Recent Developments in Pompe Disease TherapyGuo, J. / Kelton, C. M. / Guo, J. J. et al. | 2012
-
PHP24 Employee Medication Adherence: Pharmacy Claims Analysis of an Employer-Sponsored Onsite Health CenterGorman, K. M. / Boaz, K. A. / Wade, R. / Miller, R. M. et al. | 2012
-
PHP35 Determinants of Participation in Mammography Screening in TaiwanTang, C. H. / Chuang, P. Y. / Huang, Y. H. et al. | 2012
-
PHP39 The “Weight” of Orphan Drugs in the European Pharmaceutical Policy. A Focus on the Expenditure and the Utilization of Orphan Drugs in Five European Union CountriesMuscolo, L. A. / Deriu, D. / Sammarco, A. / Siviero, P. D. / Pani, L. et al. | 2012
-
PHP73 Budget Impact Analysis: Do Canadian Guidelines Meet the Needs of Public Drug Plan Managers?Abdalla, N. / Barbeau, M. / Lachaine, J. et al. | 2012
-
PHP79 Consistency Between Self-Reported and Recorded Values for Clinical MeasuresThomas, J. / Paulet, M. / Rajpura, J. R. et al. | 2012
-
PHP78 Development of a New System for Registration of Patient RegistriesGliklich, R. / Levy, D. / Campion, D. M. / Leavy, M. B. / Karl, J. / Berliner, E. / Khurana, L. / Hossfeld, W. et al. | 2012
-
PHP92 Applying Actuarial Methodology to Hosptial Data for Estimation of Medical ErrorsHorblyuk, R. / Kaplan, H. S. / Lee, D. W. / David, G. / Gunnarsson, C. et al. | 2012
-
PHP97 Perceptions on Payer-Industry Partnerships in Influence CountriesMarinoni, G. / Lockwood, C. / Kowal, S. / Gallo, P. et al. | 2012
-
PHP101 Legal Impact of Pharmaceutical Pricing in the German Statutory Health Insurance SystemGissel, C. et al. | 2012
-
PGI5 Treatment Patterns of Medicare Patients with Ulcerative Colitis Initiating Tumor Necrosis Factor Therapy: Application of a Data Visualization ToolBaser, O. / Wang, L. / Xie, L. / Yuce, H. et al. | 2012
-
PGI13 Economic Evaluation of Two Schemes of Mesalazine (Mz) Maintenance Therapy for Ulcerative Colitis in Remission: The Brazilian Public Health Care PerspectiveClark, O. A. / Nishikawa, x. M. / Paladini, L. / Faleiros, E. J. / Clark, L. G. et al. | 2012
-
PND2 Dopamine Agonists and Dyskinesia in Advanced Parkinson's Disease: A Network Meta-Analysis of Rotigotine, Pramipexole and Ropinirole As Adjunct Therapy to LevodopaSenior, E. / Dedeken, P. / Naci, H. et al. | 2012
-
PND15 Health Care Resource Utilization and Expenditures of Epilepsy in Pediatric and Adult Medicaid PopulationCramer, J. / Wang, Z. / Li, X. / Copher, R. / Powers, A. et al. | 2012
-
PND23 Economic Evaluation of Natalizumab Versus Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis in SwedenAlexopoulos, S. T. / Deniz, B. / Walker, A. R. / Arnold, R. / Bates, D. et al. | 2012
-
PND28 Mobility, Indirect Costs, and Health-Related Quality of Life in Multiple SclerosisColeman, C. I. / Roberts, M. S. / Sidovar, M. et al. | 2012
-
PND30 Health Care Resource Utilization and Quality of Life in Patients With Overactive Bladder Due to Neurogenic Detrusor Overactivity in the United Kingdom: A Database AnalysisTang, D. / Colayco, D. / Piercy, J. / Patel, V. / Globe, D. et al. | 2012
-
PND35 Fictitious Preferences or Felicitous Recoding? Conjoint Respondents Who Make Sense of Nonsensical QuestionsYang, J. C. / Johnson, F. R. et al. | 2012
-
PND58 Interconnected HTA Map for Alzheimer's Disease – Analysis of Divergence and Collaboration PatternsAndreykiv, M. / Van Engen, A. / Wiebinga, C. / Zorzi, O. / Mark, R. et al. | 2012
-
PUK16 Reduced Use of Erythropoiesis-Stimulating Agents and Intravenous Iron with Use of the Phosphate Binder Ferric Citrate: a Facility-Level Cost-Offset Model Under the Medicare BundleMutell, R. / Rubin, J. L. / Bond, T. C. / Mayne, T. et al. | 2012
-
PUK17 Economic Benefits of Slowing Progress to End Stage Renal Disease (ESRD) in Patients with Diabetes-Related Chronic Kidney Disease (DKD), Compared with Standard of Care (SOC)Smolen, L. J. / Klein, T. M. / Voelker, J. R. / Sierra-johnson, J. / Boye, M. E. et al. | 2012
-
PUK20 Cost-Utility Assessment of Sirolimus Versus Tacrolimus for Primary Prevention of Graft Rejection in Renal Transplant Recipients in MexicoRely, K. / Alexandre, P. K. / Garcí / a-Garcí / a, E. G. / Muciñ / o-Ortega, E. / Salinas-escudero, G. / Galindo-Suá / rez, R. M. et al. | 2012
-
PUK30 Once Monthly Erythropoiesis Stimulating Agent (ESA) Dosing May Reduce ESA Utilization Compared to Thrice-Weekly ESA DosingBond, T. C. / Rubin, J. L. / Wang, X. / Yang, A. et al. | 2012
-
PRM1 Compliance on the Consolidated Standards of Reporting Trials (CONSORT) Guidelines in Randomized Controlled TrialsGodwin, O. P. / Dyson, B. / Park, S. Y. / Lee, E. et al. | 2012
-
PRM19 Evaluation of Sources and Types of Patient-Reported Outcome Data for Health Care ResearchKapasi, A. J. / Kamani, S. A. / Moorthy, V. / Singh, V. P. / Nguyen-khoa, B. A. / Goehring, E. / Jones, J. K. et al. | 2012
-
PRM27 A Method of Projecting Future Co-Morbidity Prevalence and Health Service Demand in the United Kingdom Population Using the Health Improvement Network (THIN)Smith, D. A. / Butt, Z. / Mayhew, L. D. / Rickayzen, B. D. / Bhullar, H. / Dattani, H. et al. | 2012
-
PRM29 Comparison of Discrete Discounting and Non-Constant Exponential Discounting Approaches to Calcuate Future Gains in Quality-Adjusted Life-YearsGarg, V. / Raisch, D. W. et al. | 2012
-
PRM31 Evaluation of Decision Analytic Models in Cost-Effectiveness Analysis in Korea: From Guideline to PracticeBae, S. / Lee, S. / Lim, S. H. et al. | 2012
-
PRM59 Trade-Off Analysis: an Extension of Threshold Pricing AnalysisMladsi, D. M. / Graham, J. B. / Ronquest, N. et al. | 2012
-
PDB5 Efficacy and Safety of Liraglutide 1.2Mg and Exenatide 10Mcg Twice Daily in Type 2 Diabetes Mellitus: A Systemtic Review and Meta-AnalysisYe, Q. / Ploug, U. J. et al. | 2012
-
PDB7 Efficacy and Safety of Liraglutide 1.2Mg Once Daily in Type 2 Diabetes Mellitus: A Systematic Review and Meta-AnalysisYe, Q. / Ploug, U. J. et al. | 2012
-
PDB47 Direct Medical Management Costs of Diabetes-Related Complications in AlgeriaHnoosh, A. / Vega-Herná / ndez, G. / Jugrin, A. / Todorova, L. et al. | 2012
-
PDB58 Cost-Effectiveness Analyses of Type 2 Diabetes Mellitus Treatments Published in the United States: A Systematic Literature Review of Results and Quality AssessmentGarg, V. / Raisch, D. W. / Borrego, M. et al. | 2012
-
PDB102 Use of Health Care Administrative Databases to Estimate the Burden of Diabetes Mellitus: A Population-Based StudyScalone, L. / Mantovani, L. G. / Furneri, G. / Ciampichini, R. / Cortesi, P. / Beck-Peccoz, P. / Orsi, E. / Fornari, C. / Madotto, F. / Chiodini, V. et al. | 2012
-
PIH14 Economic Burden of Community Acquired Pneumonia in Older Adults in the New EU Countries of the Central EuropeTichopad, A. / Roberts, C. S. / Gembula, I. / Jahnz-Rozyk, K. et al. | 2012
-
PIH18 Regional Cost-Effectiveness Analysis of Universal Childhood Hepatitis a Vaccination in BrazilDe Soarez, P. C. / Sartori, A. M. / Novaes, H. M. / Amaku, M. / Azevedo, R. S. / Ximenes, R. A. / Martelli, C. M. et al. | 2012
-
PIH77 Annual Overall and Epilepsy-Related Health Care Utilization in Adult Epilepsy Patients in the United StatesCramer, J. A. / Wang, Z. / Chang, E. / Powers, A. / Copher, R. / Cherepanov, D. / Broder, M. et al. | 2012
-
PIH81 A Qualitative Study Evaluating Perceptions of Nurses Towards the Role of Pharmacist in PakistanSaira, A. / Hassali, M. A. / Maira Faizullah, S. / Rabeeha Khan, R. K. / Arooj Sahir, A. S. / Izhar Hussain, I. H. et al. | 2012
-
PCN1 Advanced Disease in Ovarian Cancer: Clinical and Economic Outcomes Within Hospital Inpatient SettingsTate, W. R. / Skrepnek, G. H. / Alberts, D. S. et al. | 2012
-
PCN7 Life Expectancies and Prognostic Factors of Survival in Patients With Different Types of Cancer Under Prolonged Mechanical Ventilation: A Nation-Wide Analysis of 5,138 Cases During 1998-2007Shih, C. Y. / Hung, M. C. / Lu, H. M. / Chen, L. / Wang, J. D. et al. | 2012
-
PCN49 Segmented Medical Costs of Squamous Cell Head and Neck Cancer: A Pharmacoeconomic Analysis Using a Private Insurance DatabaseReveles, I. A. / Kreys, E. D. / Corral, M. / Zhang, Y. / Koeller, J. M. et al. | 2012
-
PCN64 The Cost Effectiveness of Cetuximab Plus Best Supportive Care (BSC) Versus BSC Alone in Last Line for KRAS Wild Type Metastatic Colorectal Cancer Patient PopulationChaugule, S. / Hay, J. et al. | 2012
-
PCN76 Economic Evaluation of the Use of Erlotinib for Non-Small Cell Lung Cancer (NSCLC) With EGFR Mutation in Mexican Public Health InstitutionsLechuga, D. / Alva, M. / Gay, J. G. / Sá / nchez-Kobashi, R. et al. | 2012
-
PMS32 The Cost Effectiveness of Celecoxib Versus NSAIDs+PPI in the Treatment of Osteoarthritis in Algeria; An Update to the Nice Model Using Data from the Condor TrialMould, J. F. / Meklati, M. / Khris, M. / Kherraf, S. A. et al. | 2012
-
PMS44 Impact of Gout on Productivity and Health-Related Quality of Life Outcomes Among Patients with Hypertension in the National Health and Wellness SurveyDibonaventura, M. D. / Andrews, L. / Sternbach, N. / Yadao, A. M. / Kahler, K. H. et al. | 2012
-
PMS64 Foqus Study (Study on Factors for Osteoporosis QOL in Japanese Subjects) - Interim ReportHagino, H. / Sugimoto, T. / Souen, S. / Tanaka, K. / Endo, N. / Okazaki, R. / Nakamura, T. et al. | 2012
-
PMS94 Integrating Patient-Reported Outcomes (PRO) and Medical Record Data (MR) in Observational Study Designs: Results from a Direct-to-Patient Pilot Study in GoutCascade, E. / Marr, P. / Winslow, M. / Tuttle, D. et al. | 2012
-
PRS1 Assessing the Association of Omalizumab Use and Arteriothrombotic Events Through Spontaneous Adverse Event ReportingAli, A. K. et al. | 2012
-
PRS12 Budget Impact Analysis of Tiotropium Bromide Versus Ipratropium Bromide on the Top of Standard Therapy in the Treatment of Chronic Obstructive Pulmonary Disease (Copd) in Russian FederationKulikov, A. / Komarov, I. et al. | 2012
-
PRS13 A Budget Impact Analysis of Indacaterol for the Treatment of Chronic Obstructive Pulmonary Disease in ColombiaGiraldo, L. F. / Ariza, J. G. / Acosta, T. / Pinzon, J. F. et al. | 2012
-
PRS36 Burden of Smoking on Quality of Life and Productivity in Chronic Obstructive Pulmonary Disease (Copd)Galaznik, A. / Makinson, G. / Tripathi, S. / Zou, K. H. / Chapnick, J. / Vietri, J. et al. | 2012
-
PRS37 Evidences for the Design and Implementation of Smoking Cessation Interventions in Mexico: an Analysis of the Willingness to Pay for an Effective Method to Quit SmokingServá / n Mori, E. / Heredia Pi, I. B. / Reynales Shigematsu, L. M. / Bautista Arredondo, S. et al. | 2012
-
PRS54 Acceptability of the Self-Administered Computerized (Sac) Versions of the Baseline/Transition Dyspnea Indexes (Bdi/Tdi) for Patients with Copd from Seven CountriesBrunel, V. / Salmassi, L. / White, T. / Mahler, D. A. et al. | 2012
-
PMD2 Admission to Coronary Angiographic Catheterization in Armenia at Nork Marash Medical Center: Characteristics and OutcomesPerikhanyan, A. et al. | 2012
-
PMD15 The Economic Burden of Atrial Fibrillation among Elderly Populations in Selected Developed CountriesRizzo, J. A. / Mallow, P. / Waters, H. / Cirrincione, A. et al. | 2012
-
PMD18 Bypass Therapy Assay Testing As a Strategy to Reduce Treatment Costs for Hemophilia Patients with InhibitorsChaugule, S. / Hay, J. / Young, G. et al. | 2012
-
PMD35 Cost Effectiveness Analysis of Deoxyribonucleic Acid Chip Kit (ANDCK) for the Determination of Blood Erythrocyte VariantsTellez giron, G. / Rizzoli, A. / Soto, H. / Salgado, J. L. et al. | 2012
-
PSU6 Economic Impact of Using Sugammadex for the Reversal of Deep Neuromuscular Blockade in the Swedish Health Care SettingInsinga, R. P. / Lundberg, J. et al. | 2012
-
PSU7 Economic Burden of Obesity and the Impact of Bariatric Surgery on Health Care Costs and UtilizationYan, C. / Chuck, A. et al. | 2012
-
PSU18 Retrospective Data Analysis Assessing Hospital Costs and Resource Utilization Associated with Perioperative Blood Loss in Renal SurgeriesParikh, N. / Hashemi, L. / Morseon, M. et al. | 2012
-
PSU31 The Improvement of Quality of Life in Patients Treated with Bariatric SurgeryOh, S. H. / Song, H. J. / Lee, H. J. / Lee, J. Y. / Choi, J. E. / Kwon, J. W. et al. | 2012
-
PSU41 Day of Week of Procedure and 30-Day in-Hospital Mortality for Elective SurgeryJen, M. H. et al. | 2012
-
PMH37 Cost-Effectiveness of Asenapine in the Treatment of Bipolar I Disorder in CanadaLachaine, J. / Beauchemin, C. / Mathurin, K. / Gilbert, D. / Beillat, M. / Corson, H. et al. | 2012
-
PMH85 An Application of Group-Based Modeling Approach for Trajectory Recognition: The Developmental Courses of Hyperactivity and Inattentive SymptomsCheng, W. / Goodwin, R. / Wu, P. / Vitaro, F. / Tremblay, R. et al. | 2012
-
PSY1 Hospitalization Costs Attributable to Obesity in Patients With Adverse Drug Events in US Hospital for 2001-2009Lee, S. M. / Choi, I. S. / Yi, S. Y. / Kim, Y. S. / Suh, D. C. et al. | 2012
-
PSY6 The Impact on Sleep Quality of Butrans® (Buprenorphine) Transdermal System 5 Mcg/Hour (BTDS 5) and 20 Mcg/Hour (BTDS 20) Dosages in Patients With Moderate-to-Severe Chronic Low Back PainYarlas, A. S. / Miller, K. / Wen, W. / Shah, R. / Lynch, S. Y. / Dain, B. / Ripa, S. R. et al. | 2012
-
PSY16 A Systematic Review of Economic Studies on Biologic Agents Used to Treat Crohn's DiseaseTang, D. / Harrington, A. R. / Lee, J. K. / Armstrong, E. P. et al. | 2012
-
PSY21 Health Care Costs Associated With Postherpetic Neuralgia and its Treatment With Gabapentin and PregabalinJohnson, P. / Sweeney, M. / Becker, L. / Halpern, R. et al. | 2012
-
PSY53 Evaluation of Daily Average Consumption (DACON) of Oxycodone CR and Oxymorphone ER Using an Interrupted Time Series AnalysisPuenpatom, R. A. / Szeinbach, S. L. / Ma, L. / Ben-joseph, R. / Summers, K. H. et al. | 2012
-
PSY60 Pain Management: Observation and Side EffectsTaieb, C. et al. | 2012
-
PCV19 Venous Thromboembolism Prophylaxis and Clinical Consequences in Hospitalized Medically Ill PatientsBaser, O. / Liu, X. / Phatak, H. / Wang, L. / Mardekian, J. / Kawabata, H. / Petersel, D. / Hamilton, M. / Ramacciotti, E. et al. | 2012
-
PCV30 Analysis of Generic Simvastatin and Atorvastatin Versus Branded Rosuvastatin in Hyperlipidemia Patients: A Budget Impact Model from a Managed Care Organization Perspective in the United StatesRuff, L. / Montouchet, C. / Balu, S. et al. | 2012
-
PCV32 Health Resource Utilization of Patients with Chronic Thromboembolic Pulmonary Hypertension Versus Pulmonary Aterial Hypertension– Results of a Retrospective Study in Six European CountriesSchweikert, B. / Pittrow, D. / Gabriel, A. / Berg, J. / Sikirica, M. et al. | 2012
-
PCV38 Venous Thromboembolism: A Refined United States Cost Model with Long Term Attack RatesWoersching, A. L. / Borrego, M. / Spyropoulos, A. C. / Mahan, C. E. et al. | 2012
-
PCV52 Urapidil in Treatment of Hypertension Urgencies in the Russian Federation: Cost-Effectiveness AnalysisKulikov, A. / Protsenko, M. / Misikova, B. et al. | 2012
-
PCV95 Prevalence and Determinants of Pharmacotherapy in Myocardial Infarction PatientsShah, J. / Aparasu, R. R. / Birtcher, K. K. / Johnson, M. L. et al. | 2012
-
PCV89 Patient-, Hospital-, and County- Level Predictors of Discharges and Readmissions among Patients with Cardiovascular DiseaseOnukwugha, E. / Yong, C. et al. | 2012
-
PCN99 Preference-Based Estimates of the Health Utility Impacts of Breast Cancer in Women Ages 18-44 in the United StatesBrown, D. S. / Trogdon, J. / Ekwueme, D. U. / Chamiec-Case, L. / Tangka, F. K. / Guy, G. P. / Li, C. / Trivers, K. F. / Rodriguez, J. L. et al. | 2012
-
PCN100 Women' Preferences for Chemotherapy in the Treatment of Early Stage Breast CancerTang, C. H. / Hung, Y. W. / Sung, C. Y. / Chuang, P. Y. / Chen, T. F. et al. | 2012
-
PCN107 Examining Knowledge and Information Seeking Behaviors Towards Blood Transfusion Among Individuals With CancerNaim, A. / Gollins, J. R. / Reynolds, C. / Walls, D. et al. | 2012
-
PCN117 An Expert Panel Consensus on Medical Treatment of Non-Midgut Unresectable Neuroendocrine TumorsBenson, A. B. / Strosberg, J. R. / Fisher, G. / Malin, J. L. / Anthony, L. / Arslan, B. / Gibbs, J. F. / Greeno, E. / Iyer, R. / Kim, M. K. et al. | 2012
-
PCN127 Relationships Between Resources and Screening Rates for Breast and Cervical Cancers in JapanHamashima, C. / Goto, R. / Sano, H. et al. | 2012
-
PCN130 Evaluating Outcomes of Specialty Medication Services Through a National Health Plan Specialty Program: A Case of Oral Oncology MedicationsTschida, S. / Aslam, S. / Lal, L. / Khan, T. / Shrank, W. H. / Bhattarai, G. / Montague-Clouse, J. / Newcomer, L. N. et al. | 2012
-
PIN14 Resource Utilization and Costs of Treating Complicated Skin and Skin Structure Infections With Daptomycin or TelavancinLuo, R. / Chaudhari, P. / Gayle, J. / Pope, S. / Horn, D. et al. | 2012
-
PIN21 A Review of Economic Studies of Rubella and Rubella VaccinationBabigumira, J. B. / Morgan, I. / Levin, A. et al. | 2012
-
PIN31 Cost-Effectiveness Analysis of Antifungal Treatments Available in Colombia for the Treatment of Invasive CandidiasisMolina, F. J. / Cortes, J. A. / Soto, R. / Lemos, E. V. / Gutierrez-Ardila, M. V. / Nuñ / ez, S. M. et al. | 2012
-
PIN43 Cost Effectiveness Analysis of the Combination Tenofovir (TDF) /Emtricitabina (FTC)+ Efavirenz (EFV) in HIV-Infected NaÏve Patients in MexicoSoto molina, H. / Pizarro, M. / Vargas, G. / Rizzoli, A. et al. | 2012
-
PIN67 Extended Cox Model Analysis With Non-Proportional Hazards Applied in Real-World Observational DataJi, X. / Gao, X. / Baddley, J. W. / Chambers, R. / Solem, C. T. / Stephens, J. M. et al. | 2012
-
PSS7 Health Care Costs and Utilization for Privately Insured Patients Treated for Non-Infectious Uveitis in the United StatesJohnson, S. / Duh, M. S. / Mallya, U. / Diener, M. / Sorg, R. / Chu, D. et al. | 2012
-
PSS23 Limited Role of Marital Status in the Impact of Dermatological Diseases on Quality of LifeTabolli, S. / Pagliarello, C. / di Pietro, C. / Abeni, D. et al. | 2012
-
PMS10 The Cost of Hospitalisation for Knee Osteoarthritis in France in 2010Taieb, C. et al. | 2012
-
PMS17 Cost Minimization of Anti-TNF Biologics in the Treatment of Rheumatoid Arthritis, Akylosing Spondylitis and Psoriatic Arthritis in the Brazilian Public Health Care SystemMorais, A. D. / Pereira, M. L. et al. | 2012
-
PMS28 Economic Evaluation of the Use of Anti TNF's and Tocilizumab for the Treatment of Systemic Juvenile Idiopathic Arthritis (sJIA) in MexicoLechuga, D. / Alva, M. / Carlos, F. et al. | 2012
-
PMS40 Medication Adherence among Patients with Rheumatoid ArthritisDatar, M. / Khanna, R. / Pace, P. F. / Mahabaleshwarkar, R. / Basak, R. S. / Banahan, B. F. et al. | 2012
-
PMS69 Tumor Necrosis Factor Blocker Dose Escalation among Biologic Naïve Rheumatoid Arthritis (RA) Patients in Commercial Managed Care Plans in the Two Years Following Therapy InitiationBonafede, M. / Gandra, S. R. / Fox, K. M. / Wilson, K. et al. | 2012
-
PMS72 Evaluation of Clinical Performance and Variation among Three Types of Patients with Rheumatoid Arthritis: Opportunities to Raise Quality and Lower CostsPeabody, J. / Strand, V. / Chernoff, D. / Ta, H. et al. | 2012
-
PMS83 Adherence and Uric Acid Goal Attainment with Urate Lowering Therapy in Patients with GoutRashid, N. / Cheetham, C. T. / Niu, F. et al. | 2012
-
PMS82 Factors Associated with Initiation of High-Dose Duloxetine among Patients with OsteoarthritisPeng, X. / Wu, N. / Andrews, J. S. / Chen, S. Y. / Boulanger, L. et al. | 2012
-
PMS84 Derivation of Severity Index for Rheumatoid Arthritis and its Effect on Health Care OutcomesBaser, O. / Wang, L. / Xie, L. / Du, J. / Wang, H. et al. | 2012
-
PRS2 Evaluating the Incidence of Side Effects in Newly Diagnosed Tuberculosis Patients of Khyber Pakhtoon KhuwaSaira Azhar, D. S. / Arooj Sahir, A. S. / Rabeeha Khan, R. K. / Maira Faizullah Shah, M. F. / Izhar Hussain, I. H. et al. | 2012
-
PRS6 Impact of Omalizumab on Emergency-Department Visits, Hospitalizations and Corticosteroid Use in Patients with Uncontrolled Asthma Using High-Dose Inhaled CorticosteroidsLafeuille, M. H. / Dean, J. / Zhang, J. / Duh, M. S. / Gorsh, B. / Lefebvre, P. et al. | 2012
-
PRS15 Cost-Effectiveness of Azithromycin and Clarithromycin Treatments for Community Acquired Pneumonia Requiring Hospitalization for Immunocompetent Individuals of Age 65 and Older, from Public Perspective in BrazilFujii, R. K. / Mould, J. F. / Lanzara, G. D. / Manfrin, D. F. et al. | 2012
-
PRS28 Burden of Smoking on Productivity in Chronic Obstructive Pulmonary Disease (Copd)Galaznik, A. / Makinson, G. / Tripathi, S. / Zou, K. H. / Chapnick, J. / Vietri, J. et al. | 2012
-
PRS40 Measurement of Primary Medication Adherence among Children with Asthma Using Administrative Claims DataVaidya, V. / Lehman, J. A. / Balkrishnan, R. et al. | 2012
-
PRS53 Test-Retest Reliability of the Urticaria Patient Daily Diary in Electronic Format among Adults and AdolescentsFlood, E. / Devlen, J. / Zazzali, J. et al. | 2012
-
PSU25 Clinical and Cost Effectiveness of Bariatric Surgery for Obese Patients: Economic Evaluation in South KoreaSong, H. J. / Lee, H. J. / Lee, J. Y. / Choi, J. E. / Oh, S. H. / Kwon, J. W. et al. | 2012
-
PSU21 Health Care Costs and Utilization Between Patients Receiving Total Knee Replacement Surgery With and Without Muscle Atrophy/WeaknessChen, S. Y. / Lee, Y. C. / Wu, N. / Zhao, Y. et al. | 2012
-
PMH1 Pharmacotherapy and Associated Outcomes in Pediatric Bipolar DepressionBhowmik, D. / Chen, H. / Aparasu, R. R. / Rajan, S. / Sherer, J. T. / Perez, M. O. et al. | 2012
-
PMH3 Acne Drug Therapy and the Development of Comorbid Major Depressive Disorder in the United StatesLin, H. C. / Clodfelter, R. P. / Lee, C. H. / Balkrishnan, R. / Feldman, S. R. et al. | 2012
-
PMH12 National Trends of Psychotropic Medication Use among Patients Diagnosed with Anxiety Disorders: Results from the Medical Expenditure Panel Survey 2004-2009Wu, C. H. / Wang, C. C. / Katz, A. J. / Farley, J. et al. | 2012
-
PMH21 A Systematic Review of Effect of Antipsychotic Agents on Mortality in SchizophreniaKamble, P. S. / Mullen, P. D. / VonVille, H. / Aparasu, R. R. et al. | 2012
-
PMH41 Antidepressant Treatment Patterns, Health Care Utilization and Cost among Patients with Major Depressive Disorder (MDD)Isenberg, K. / Eisenberg, D. / Sanchez, R. / Alvir, J. / Wang, J. / Gu, T. / White, J. et al. | 2012
-
PMH52 Levomilnacipran in the Treatment of Major Depressive Disorder: Functional Health and Well-Being Efficacy Results from a Phase III Clinical TrialBlum, S. I. / Tourkodimitris, S. / Ruth, A. et al. | 2012
-
PMH59 Burden of Disease in Patients with Diagnosed Depression in Brazil: Results from 2011 National Health and Wellness Survey (NHWS)Mould, J. F. / Fujii, R. K. / Paganini, P. / Manfrin, D. F. et al. | 2012
-
PSY13 Effect of Risk-Share Agreements on Budget Impact: A Case Study of Certolizumab Pegol in the Treatment of Rheumatoid ArthritisFust, K. / Parthan, A. / O' / Sullivan, A. K. / Bedenbaugh, A. et al. | 2012
-
PSY17 Economic Burden Associated With Workplace Productivity Losses (WPL) in Patients With Psoriasis in a Population in the United StatesZhang, F. / Guerin, A. / Gauthier, G. / Day, R. / Khan, Z. et al. | 2012
-
PSY22 Health Care Costs for Inflammatory Bowel Disease Patients who are Adherent Versus Non-Adherent With Infliximab TherapyWan, G. / Kozma, C. / Slaton, T. / Olson, W. / Feagan, B. et al. | 2012
-
PCV4 Thromboprophylaxis and the Risk of Post-Discharge Venous Thromboembolism and Bleeding in Patients Undergoing Total Hip or Knee ArthroplastyHuo, M. H. / Spencer, D. L. / Fan, Y. / Borah, B. J. / Mills, R. M. / Klaskala, W. et al. | 2012
-
PCV6 Risk of Adverse Cardiovascular Outcomes Associated with Concomitant Use of Clopidogrel and Proton Pump Inhibitors in Elderly Medicare BeneficiariesMahabaleshwarkar, R. / Yang, Y. / Datar, M. / Bentley, J. P. / Strum, M. / Banahan, B. F. / Null, K. D. et al. | 2012
-
PCV10 Are the Statins Effective to Prevent First Myocardial Infarction in Real Life?Grimaldi, L. / Rossignol, M. / Danchin, N. / Dallongeville, J. / Bruckert, E. / Khachatryan, A. / Benichou, J. / Abenhaim, L. et al. | 2012
-
PCV24 Congestive Heart Failure Gap Analysis. Population Perspectives from Lake County, IL, USARasty, S. / Dubois, M. / Soliman, W. et al. | 2012
-
PCV27 Survival to Discharge After Cardiac Arrest in a Pediatric Population: Results from the Kids' Inpatient Database, 2003-2009 in the United StatesForde, T. W. / Heaton, P. C. / Czosek, R. / Kelton, C. M. et al. | 2012
-
PCV42 Cost Analysis of Venous Thromboembolism Prophylaxis After Total Knee Replacement and Total Hip ReplacementMarmarali, B. / Altintas, F. / Bal, K. / Bozkurt, K. / Demir, M. / Erdemli, B. / Ince, B. / Ongen, G. / Deger, C. / Parali, E. et al. | 2012
-
PCV50 Cost Effectiveness Analysis of Azilsartan Medoxomil and Chlorthalidone Fixed Dose Combination Therapy for Treatment of HypertensionArikian, S. R. / Corvino, F. A. / Zivkovic, M. / Hagan, M. et al. | 2012
-
PCV79 Survey of Patients with Atrial Fibrillation on the Use of Warfari and DabigatranChoi, J. C. / Dibonaventura, M. D. / Kopenhafer, L. / Nelson, W. W. et al. | 2012
-
PCV96 Trends in Utilization for Rate-Control and Rhythm-Control Drugs from 2001 to 2009: Results from the National Ambulatory Medical Care SurveyDesai, A. M. / Cavanaugh, T. / Desai, V. C. / Heaton, P. C. / Kelton, C. M. et al. | 2012
-
PHP49 Reference Pricinig Proposal Based on Gross Domestic Product Per CapitaKockaya, G. / Wertheimer, A. / Kı / lı / c, P. / Daylan Kockaya, P. et al. | 2012
-
PHP52 Root Cause Analysis of Discarded Drugs in TaiwanHuang, S. Y. / Ko, C. C. / Chang, Y. C. / Chen, Y. C. / Weng, W. S. / Yang, W. C. / Chien, H. Y. et al. | 2012
-
PHP62 Prescribing Evaluation Program in South KoreaLee, B. R. / Lee, S. M. / Kim, S. K. et al. | 2012
-
PHP64 The Incidence of Potential Drug-Drug Interactions Originating From the Same PrescriberMalone, D. C. / Hines, L. E. / Brown, S. / Warholak, T. L. et al. | 2012
-
PHP67 Geographic Disparities in Receiving Preventive Care Among Older IndividualsBhagnani, T. D. / Wu, W. K. et al. | 2012
-
PHP70 E-Prescribing Trends in the United States: 2008-2012Hufstader, M. / Furukawa, M. / Hogin, E. et al. | 2012
-
PHP90 Case-Mix Adjustment of Adherence-Based Pharmacy Quality Indicator ScoresDharmarajan, S. / Banahan, B. F. / Bentley, J. P. / West-Strum, D. et al. | 2012
-
PHP94 The US Orphan Drug Landscape: Before and After EU Orphan Drug Legislation of 2000Bachman, E. M. / Kumar, J. / Zaidi, Q. et al. | 2012
-
PHP96 Examination of Value Drivers in the Adoption of Wellness Programs for Chronic DiseasesCabo, R. / Nanjundaiah, B. / Amato, S. et al. | 2012
-
PHP110 Review and Comparison of Different National Guidelines on the Implementation of Network Meta-AnalysisHawkins, N. / Laws, A. J. / Kendall, R. M. et al. | 2012
-
PMS4 Comparative Analysis Between Costs and Clinical Response of Biologic Drugs for the Treatment of Rheumatoid Arthritis (RA)Cantanheda, C. R. / Romã / o, V. A. / Amino, J. G. / Dias, Q. C. / Simas, H. S. / Bacchiega, A. B. / Azevedo, V. / Assis, E. / Teich, V. T. et al. | 2012
-
PCV108 Measuring the Impact of Tobacco Control Policies on Health Outcomes Using the TOSCA (Tobacco Policy Outcomes and Smoking Cessation) ModelDe nigris, E. / Bowrin, K. / Kunst, A. E. / Roberts, G. et al. | 2012
-
PGI7 Factors Associated with Breakthrough Symptoms and OTC Use Among Gerd Patients in a Real-World SettingSolem, C. T. / Mody, R. R. / Stephens, J. M. / Macahilig, C. / Yu, S. / Gao, X. et al. | 2012
-
PGI20 Pre- to Post-Diagnosis Increase in Utilization and Costs of Chronic-Use Medications and Other Medical Resources in Managed Care Enrollees with DiverticulitisDavis, K. L. / Yen, L. / Loftus, E. V. / Hodgkins, P. et al. | 2012
-
PGI25 Cost Effectiveness of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Peginterferon Alfa Plus Ribavirin in the Treatment of Chronic Hepatitis C (CHC) in Previously Untreated Genotype I PatientsFonseca, M. / Tannus, G. / Parisi, E. et al. | 2012
-
PND9 Huntington's Disease (HD) Direct Medical Costs: A Retrospective Claims Database AnalysisDivino, V. / Smith, P. / DeKoven, M. / Warner, J. H. / Anderson, K. E. / Giuliano, J. / Langbehn, D. / Lee, W. C. et al. | 2012
-
PUK1 the Effect of Coadminstration of Nicotinamide and Calcium-Based Phosphate Binder on Hyperphophatemia in Patients Undergoing HemodialysisAllam, S. / El-Hamamsy, M. / El Sharkawy, M. et al. | 2012
-
PUK6 Medication Adherence in Hemodialysis Patients Treated with Phosphate BindersYusuf, A. A. / St. Peter, W. et al. | 2012
-
PUK9 Estimation of Prevalence and Economic Burden of Acute Kidney Injury from a Managed Care Database in the United StatesHopkins, B. / Obi-tabot, E. / Wang, H. / Wang, Y. / Blount, T. / Muszka, J. et al. | 2012
-
PUK32 Lower Case Mix Adjusters are Associated with Lower Erythropoiesis-Stimulating Agent (ESA) and Other Bundled CostsSibbel, S. P. / Rubin, J. L. / Yang, A. et al. | 2012
-
PUK34 Validation of ICD-9 Codes for the Identification of Patients with Stage 3-5 Chronic Kidney Disease in Administrative Claims DataGrabner, M. / Chen, Y. / Palli, S. R. / Quimbo, R. A. et al. | 2012
-
PRM9 Relevance and Quality of the Pharmacoeconomic Literature of FDA Recently Approved Drugs: A Systematic ReviewWoersching, A. L. / Raisch, D. W. / Borrego, M. et al. | 2012
-
PDB18 Validation of a Diabetes Modeling FrameworkFuriak, N. / Bansal, M. / Gahn, J. C. / Klein, R. W. / Smolen, H. J. et al. | 2012
-
PDB20 Estimated Prevalence of Hypoparathyroidism in the United States Using a Large Claims Database and Disease Severity From Primary Market ResearchPowers, J. / Ruscio, A. / Saunders, B. / Joy, K. / Lagast, H. et al. | 2012
-
PDB37 The Cost of Hypoglycemic Events Associated With Diabetes: A Retrospective Claims Database StudyPietri, G. / Kennedy, K. / Bouchard, J. / Goldhammer, M. et al. | 2012
-
PDB74 Patient Reported Access to Health Care in Patients With Diabetes and Obesity: Study on Medical Panel Expenditure Survey (2008)Kakad, S. N. / Franzini, L. et al. | 2012
-
PDB77 Health-Related Quality of Life by Assessment of Cardiovascular Disease (Cvd) Risk in Patients with Type 2 Diabetes: Korean Qudit of Diabetes-Dependent Quality of Life (Kr-Addqol)Kim, D. M. / Kim, S. G. / Lee, W. Y. / Kim, C. H. / Kim, C. S. / Cho, D. H. / Won, G. J. / Kim, Y. J. et al. | 2012
-
PDB87 Real-World Retrospective Analysis of Demographic Characteristics and Prevalence of Diabetes in Shanghai Minhang DistrictHuang, Y. / Xu, Z. / Xu, S. / Chen, W. et al. | 2012
-
PIH1 The Clinical Consequences of Exposure to Clinically Important Drug-Drug InteractionsMalone, D. C. / Hines, L. E. / Brown, S. et al. | 2012
-
PIH9 Dietary Supplement Use in the United States: National Health and Nutrition Examination Survey (NHANES), 2007-2009Alhammad, A. M. / Harpe, S. E. et al. | 2012
-
PIH11 Prevalence and Incidence Rates of Most Common Comorbid Conditions among Patients with Tuberous Sclerosis Complex: A Naitonal Claim Database AnalysisSun, P. / Liu, Z. / Kohrman, M. et al. | 2012
-
PIH41 Evaluating the Perception of General Public Towards the Role of Pharmacist in Health Care System of PakistanSaira, A. / Hassali, M. A. / Hussain, I. et al. | 2012
-
PIH55 Use of PRO Analysis in Health Technology AssessmentsRubinstein, E. / Jaksa, A. / Ho, Y. S. / Daniel, K. et al. | 2012
-
PIH56 Measuring Quality of Life in Facial Aesthetic Patients: Field-Testing of a New Modular System (the FACE-Q)Pusic, A. / Klassen, A. / Scott, A. / Price, A. / Cano, S. et al. | 2012
-
PIH63 Health Related Quality of Life Trajectories among General Population in the State of Penang, Malaysia Using SF-36V2 Health SurveyAtif, M. / Sulaiman, S. A. / Shafie, A. A. / Hassali, M. A. / Saleem, F. et al. | 2012
-
PIH79 Medication Adherence and Persistence for Hypogondal Patients Treated with Topical Testosterone Therapy: A Retrospective Claims AnalysisSchoenfeld, M. J. / Shortridge, E. / Cui, Z. / Shen, W. / Muram, D. et al. | 2012
-
PCN6 Are Qaly Gains for New Pharmaceuticals Increasing in Cancer But Not Other Diseases?Thorat, T. / Chambers, J. D. / Neumann, P. J. et al. | 2012
-
PCN21 Impact of Anticholinergic Load of Medications on the Length of Stay of Cancer Patients in Hospice CareGupte, K. P. / Wu, W. K. et al. | 2012
-
PCN96 A Systematic Review of Health State Utilities in Patients With Advanced Hepatocellular CarcinomaZhang, Y. / Plested, M. / Hettle, R. / Orsini, L. S. et al. | 2012
-
PCN104 Performance Status of Patients With Advanced Melanoma Over Time in Routine Clinical PracticeSadetsky, N. / Zhao, Z. / Barber, B. / Wagner, V. et al. | 2012
-
PCN103 Variation in Health-Related Quality of Life by Age Among Patients With Chronic Lymphocytic LeukemiaPashos, C. L. / Flowers, C. R. / Weiss, M. / Lamanna, N. / Farber, C. / Kipps, T. J. / Lerner, S. / Kay, N. / Sharman, J. / Grinblatt, D. L. et al. | 2012
-
PCN136 Oncology Drug Prices in the United States and the United Kingdom: Implications for Pricing Strategy and Drug AccessAggarwal, S. et al. | 2012
-
PCN139 Blood Transfusion Utilization in Chemotherapy-Induced Anemia—an Analysis of Hospital Inpatient and Outpatient Records in the United StatesForlenza, J. B. / Herrera, A. / Scaife, J. / Prifti, K. / Foster, T. / Boswell, E. et al. | 2012
-
PCN143 Cancer Surveillance Using Administrative Data: Hospital-Based Services for Lung CancerBlanchette, C. M. / Craver, C. W. / Belk, K. W. et al. | 2012
-
PCN148 The Use of Personalised Medicine in Cancer TrialsWilson, T. J. / Hamerslag, L. / Kusel, J. / Brooks-Rooney, C. / Rolfe, F. / Costello, S. et al. | 2012
-
PIN8 The Economic Impact of Adding Ceftaroline Fosamil to Hospital Formulary for Community Acquired Bacterial Pneumonia: A Hospital Budget Impact Analysis in the United StatesHuang, X. Y. / Lodise, T. / Friedland, D. / Beresford, E. J. et al. | 2012
-
PIN24 Cost-Benefit Analysis of Hospital Based Postpartum Vaccination With Combined Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (TDAP)Ding, Y. / Hay, J. / Yeh, S. H. / Zangwill, K. M. et al. | 2012
-
PIN36 Cost-Effectiveness Analysis of Voriconazole Versus Amphotericin B Deoxycholate in the Treatment of Invasive Pulmonary Aspergillosis in ColombiaLemos, E. V. / Cortes, J. / Gutierrez-Ardila, M. V. / Nuñ / ez, S. M. / Prieto, H. A. et al. | 2012
-
PIN41 Cost-Effectiveness of Vaccination Against Yellow Fever in GhanaAnkrah, D. et al. | 2012
-
PIN44 From Randomized Controlled Trials to Real World: The Coala StudyFoglia, E. / Restelli, U. / Bonizzoni, E. / Bonfanti, P. / Rizzardini, G. / Ricci, E. / Porazzi, E. / Scolari, F. / Vanzago, A. / Croce, D. et al. | 2012
-
PSS14 Economic Analysis of Etanercept as Paused Therapy in Moderate to Severe Psoriasis from a Public Perspective in BrazilFernandes, R. A. / Takemoto, M. L. / Amaral, L. M. / Cruz, R. B. / Mould, J. F. / Fujii, R. K. / Brandt, H. / Almeida, G. R. / Manfrin, D. F. et al. | 2012
-
Editorial Board| 2012
-
CO1 Individual Decisions and Social Value: A Conceptual Framework to Explore Alternative Decision Making Approaches and the Value of Heterogeneity in the Era of Individualized CareEspinoza, M. A. / Manca, A. / Sculpher, M. J. / Claxton, K. et al. | 2012